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ABSTRACT 
 
Skeletal muscle health is a key determinant of functional capacity in adults. It 
allows for locomotion and activities of daily living, and as a metabolically active tissue, it 
contributes substantially to energy expenditure. The amount of skeletal muscle is 
determined by the balance between anabolism (protein synthesis) and catabolism 
(protein degradation). As such, it is worthwhile to investigate any nutritional strategies 
that can maintain or promote net addition of muscle tissue, and can prevent age-related 
declines in skeletal muscle mass.  
The importance of skeletal muscle is magnified in conditions of weight loss. A 
multitude of animal and clinical studies have shown that isocaloric substitution of dietary 
protein for carbohydrate within the Dietary Reference Intakes (DRI) promotes favorable 
outcomes during weight loss, including increased retention of lean body mass and 
improved insulin sensitivity. These results are typically attributed to satiety effects or to 
diet induced thermogenesis, which fail to consider the unique ability of dietary protein to 
affect metabolic signaling. The amount of carbohydrate and protein in a meal has a 
profound effect on the post-prandial metabolic activity of liver, skeletal muscle, and 
adipose. A study was conducted to evaluate the post-prandial responses of these 
tissues to a range of diets varied in the dietary carbohydrate / protein ratio. 
Consumption of a diet with a high carbohydrate / protein ratio induced a metabolic shift 
characterized by post-prandial hyperinsulinemia, reduced insulin sensitivity in skeletal 
muscle at the expense of adipose, an increased capacity for de novo lipogenesis, and 
activation of the integrated stress response in liver, all of which were associated with a 
decline in body composition quality. These data highlight an important, 
underappreciated aspect of dietary protein to favorably impact whole-body metabolic 
activity and body composition.  
Numerous research groups have demonstrated the acute effects of dietary 
protein and / or leucine on muscle protein synthesis (MPS). However, it was unclear if 
this acute response would translate into net accretion of muscle mass and changes in 
body composition when applied over time. Rats were fed 3 meals per day of isocaloric, 
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isonitrogenous diets that varied in protein source with different leucine enrichments 
(WHEAT, 6.8% leucine; or WHEY, 10.9% leucine) for 11 weeks. At both 2 and 11 
weeks, MPS was acutely stimulated by consumption of a standard 4 gram meal in 
WHEY but not WHEAT. Changes in MPS resulted in increased muscle mass, reduced 
fat mass, and greater diet-induced energy expenditure. At 11 weeks, gastrocnemius 
muscle weight was greater while body fat % was lower in WHEY-consuming animals. 
Interestingly, WHEAT-consuming animals had larger epididymal fat pad mass and 
greater total fat mass despite identical caloric input. Additionally, WHEAT preferentially 
partitioned dietary energy to fat while WHEY partitioned energy to lean tissue. These 
outcomes were associated with an induction of genes in skeletal muscle involved in 
mitochondrial biogenesis (e.g., PGC-1α, Tfam, cytochrome B) by WHEY. These data 
suggest that repeated consumption of leucine-rich meals stimulates MPS and presents 
the cell with dynamic and increased energy demands, provoking a response in the 
molecular machinery responsible for oxidation and energy production. 
It has been well-established that the essential, branched-chain amino acid 
leucine has a unique ability to promote anabolism in skeletal muscle. Leucine stimulates 
mammalian target of rapamycin (mTOR), which subsequently activates a signaling 
cascade that increases muscle protein synthesis (MPS) through initiation factors such 
as p70 S6 kinase (p70S6K) and eukaryotic initiation factor 4E binding protein1 (4E-
BP1). Our research group has shown that the leucine content of a meal predicts the 
acute response of MPS based on its ability to elevate the post-prandial plasma leucine 
concentration. Once stimulated, and yet despite continued elevations in plasma leucine 
and associated translation initiation factors (e.g., p70S6K and 4E-BP1), MPS returns to 
basal levels ~3 hours after a meal. However, administration of additional nutrients in the 
form of carbohydrate, leucine, or both ~2 hours after a meal was able to extend the 
elevation of MPS. This effect was associated with decreases in translation elongation 
activity as well as with increases in the AMP / ATP ratio and in the activity of 5’ 
adenosine monophosphate-activated kinase (AMPK), a key cellular energy sensor. 
These data suggest that leucine-stimulated increases in MPS result in an acute cellular 
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energy deficit that in turn is likely responsible for the subsequent restoration of MPS 
activity to basal levels.  
A study was designed to determine if AMPK directly responds to the MPS-
induced deficit in cellular energy by inhibiting translation initiation, thusly inhibiting 
subsequent MPS activity. Rapamycin was administered to inhibit the leucine-induced 
stimulation of MPS, and separately compound C was administered to inhibit AMPK 
activity. Rapamycin appropriately inhibited mTOR signaling (Akt) and presumably MPS 
activity; however, compound C did not inhibit AMPK as anticipated. Further analysis of 
the experiment was abandoned due to failure of the key inhibitor compound C.  
In total, this research demonstrates that consumption of a whole meal enriched in 
leucine acutely impacts cellular energy by activating protein synthesis in muscle, which 
compounded over time, promotes a repartitioning of energy and favorable body 
composition. These findings suggest that a substantial proportion of the observed 
benefits from increased protein consumption during meals is due to metabolic signaling 
effects and the associated energy costs, which are not appropriately captured in the 
traditional “diet as substrate” paradigm. 
v 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DEDICATION 
 
This dissertation is dedicated to my grandfather, James Kord,  
who cultivated my love for science at an early age. 
vi 
 
ACKNOWLEDGEMENTS 
 
First and foremost, I owe a great deal of thanks to my advisor, Dr. Donald 
Layman, who provided critical guidance throughout the course of my doctoral work, 
from training in animal research to manuscript preparation. I am particularly grateful for 
his willingness to give me the freedom to be involved in numerous areas of science, 
which ultimately led me to a research question that I could call my own. 
I am grateful for my lab mates from the Layman lab – Suzanne Devkota, Denise 
Lasker, Layne Norton, and Gabe Wilson – for their hard work, collaboration, and 
camaraderie during our mutual challenges and triumphs. 
I would like to thank Dr. Manabu Nakamura and Dr. Ken Wilund, not only for their 
participation on my doctoral committee, but for the extended consultation and feedback 
I received from them throughout my time at Illinois. Similarly, I am appreciative of Dr. 
Jongsook Kemper, who provided me with exposure to a new field and encouraged me 
to pursue my own perspective in it, and who additionally served on my committee. 
No student departs from the Division of Nutritional Sciences without a wealth of 
organizational support. This was ably supplied to me by Linda Barenthin, and 
subsequently by Dr. Jessica Hartke and Arena Jackson. Furthermore, I am indebted to 
both Dr. Sharon Donovon and Dr. Rodney Johnson for their leadership as Directors of 
the Division during my tenure.   
I would like to thank Ann Kruk, Jenny Westerkamp, and Adam Schlitz, who as 
undergraduate research assistants provided valuable support, particularly during the 
taxing periods of animal feeding. 
Finally, I could not have accomplished this task without the undying 
encouragement of my parents John and Susan Moulton, who never doubted my pursuit 
and always believed in my ability to succeed. 
 
vii 
 
TABLE OF CONTENTS 
 
LIST OF ABBREVIATIONS ............................................................................................ix 
PREFACE .......................................................................................................................xi 
CHAPTER I: REVIEW OF LITERATURE ....................................................................... 1 
     INTRODUCTION........................................................................................................ 1 
     SKELETAL MUSCLE AND BODY COMPOSITION ................................................... 1 
     SKELETAL MUSCLE AND ENERGY EXPENDITURE .............................................. 2 
     DIETARY PROTEIN AND BODY COMPOSITION..................................................... 3 
     LEUCINE AND MUSCLE PROTEIN SYNTHESIS ..................................................... 3 
     DIETARY LEUCINE AND BODY COMPOSITION ..................................................... 4 
     DIETARY PROTEIN AND THERMOGENESIS.......................................................... 6 
     LEUCINE AND MITOCHONDRIA .............................................................................. 8 
     CELLULAR ENERGETICS AND PROTEIN SYNTHESIS.......................................... 9 
     SUMMARY............................................................................................................... 10 
     REFERENCES......................................................................................................... 12 
CHAPTER II: METABOLIC RESPONSES TO DIETS REPRESENTING THE UPPER 
AND LOWER ENDS OF THE ACCEPTABLE MACRONUTRIENT DISTRIBUTION 
RANGE BECOME LESS FAVORABLE AS THE DIETARY CARBOHYDRATE / 
PROTEIN RATIO INCREASES .................................................................................... 18 
     INTRODUCTION...................................................................................................... 18 
     METHODS ............................................................................................................... 20 
     RESULTS................................................................................................................. 22 
     DISCUSSION........................................................................................................... 24 
     REFERENCES......................................................................................................... 29 
     FIGURES AND TABLES .......................................................................................... 32 
CHAPTER III: DIETARY LEUCINE CONTENT OF ISOCALORIC, ISONITROGENOUS 
MEALS INFLUENCES BODY COMPOSITION, ENERGY PARTITIONING, AND 
MITOCHONDRIAL HOMEOSTASIS ............................................................................ 41 
     INTRODUCTION...................................................................................................... 41 
     METHODS ............................................................................................................... 43 
viii 
 
     RESULTS................................................................................................................. 47 
     DISCUSSION........................................................................................................... 49 
     REFERENCES......................................................................................................... 52 
     FIGURES AND TABLES .......................................................................................... 54 
CHAPTER IV: THE POST-PRANDIAL MUSCLE PROTEIN SYNTHESIS RESPONSE 
IS EXTENDED WITH SUPPLEMENTAL LEUCINE OR CARBOHYDRATE BY 
DELAYING CELLULAR ENERGY DEPLETION .......................................................... 60 
     INTRODUCTION...................................................................................................... 60 
     METHODS ............................................................................................................... 62 
     RESULTS................................................................................................................. 65 
     DISCUSSION........................................................................................................... 66 
     REFERENCES......................................................................................................... 71 
     FIGURES AND TABLES .......................................................................................... 73 
CHAPTER V: SUMMARY AND SPECULATIONS ....................................................... 81 
     DIETARY PROTEIN IMPROVES BODY COMPOSITION ....................................... 81 
     DIETARY LEUCINE IMPROVES BODY COMPOSITION........................................ 82 
     DIETARY LEUCINE AFFECTS MITOCHONDRIA................................................... 83 
     POST-PRANDIAL NUTRIENTS IMPACT CELLULAR ENERGY............................. 83 
     LIMITATIONS AND FUTURE DIRECTIONS............................................................ 84 
     CONCLUSION ......................................................................................................... 85 
     REFERENCES......................................................................................................... 86 
     FIGURES ................................................................................................................. 87 
ix 
 
LIST OF ABBREVIATIONS 
 
4E-BP1 – eukaryotic initiation factor 4E binding protein 1 
ACC – acetyl-CoA carboxylase 
AICAR – 5-aminoimidazole-4-carboxamide 1-beta-d-ribonucleoside 
AIN-93G – American Institute of Rodent Diets for growth, pregnancy, and lactation 
AIN-93M – American Institute of Rodent Diets for adult maintenance 
AMDR – acceptable macronutrient distribution ratio 
AMP – adenosine monophosphate 
AMPK – 5’ adenosine monophosphate-activated protein kinase 
ANOVA – analysis of variance 
ATF3 – activating transcription factor 3 
ATP – adenosine triphophate 
BCAA – branched chain amino acid 
BCAT – branched chain amino acid transferase 
BMI – body mass index 
cDNA – complementary deoxyribonucleic acid 
CHO – carbohydrate  
DASH – Dietary Approaches to Stop Hypertension 
DIT – diet induced thermogenesis 
DRI – Dietary Reference Intakes 
DXA – dual-energy x-ray absorptiometry 
EDTA – ethylene diamine tetraacetic acid 
eEF2 – eukaryotic elongation factor 2 
EGTA – ethylene glycol tetraacetic acid 
ERRα – estrogen-related receptor alpha 
FAS – fatty acid synthetase 
FSR – fractional synthetic rate 
GLUT4 – glucose transporter 4 
GSK-3β – glycogen synthase kinase 3 beta 
x 
 
GTP – guanosine triphosphate 
HbA1c – glycosylated hemoglobin  
HCLP – high carbohydrate, low protein 
HEPES – hydroxyethyl piperazineethanesulfonic acid 
IRS-1 – insulin receptor substrate 1 
kDa – kilodalton  
LC – leucine + carbohydrate 
LCHP – low carbohydrate, high protein 
LEU – leucine  
LSD – Fisher’s least significant difference 
MCMP – moderate carbohydrate, moderate protein 
MPD – muscle protein degradation 
MPS – muscle protein synthesis 
mRNA – messenger ribonucleic acid 
mtDNA – mitochondrial deoxyribonucleic acid 
mTOR – mammalian target of rapamycin 
NRF1/2 – nuclear respiratory factors 1 & 2 
p70S6K – 70-kilodalton ribosomal protein S6 kinase 
PGC-1α – peroxisome proliferator activated receptor γ coactivator 1α 
PI3K – phosphoinositide 3-kinase 
RIA -- radioimmunoassay 
RNA – ribonucleic acid 
RT-PCR – reverse transcriptase polymerase chain reaction 
SDS-PAGE – sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SEM – standard error of the mean 
SOD1 – super oxide dismutase 1 
SREBP-1c – sterol regulatory element-binding protein 1c 
Tfam – transcription factor A, mitochondrial 
USDA – United States Department of Agriculture 
xi 
 
PREFACE 
 
The aim of this dissertation is to better understand the positive influence of 
dietary protein and the essential amino acid leucine on body composition and energy 
partitioning. Studies in animals and humans indicate that moderate increases in dietary 
protein at the expense of carbohydrate support skeletal muscle health and favorably 
impact overall body composition. However, when characterizing this response, 
potentially unique metabolic signaling effects of dietary protein have not been 
accounted for. Consequently, Chapter II will evaluate the metabolic response of skeletal 
muscle, adipose, and liver, as well as the resultant body compositions to diets varied in 
the carbohydrate / protein ratio. 
One aspect of dietary protein that is well understood is the ability of the 
component branched chain amino acid (BCAA) leucine to acutely activate mammalian 
target of rapamycin (mTOR), which subsequently stimulates muscle protein synthesis 
(MPS). It is yet unclear if repeated leucine-mediated stimulations of MPS ultimately 
result in net gain of lean muscle mass. Chapter III will explore this problem by 
chronically feeding discrete meals that are identical in total energy and macronutrient 
distribution, but vary in leucine density. Additionally, this chapter will address the 
potential for dietary leucine to influence tissues other than skeletal muscle as well as 
whole-body energy partitioning.  
Separately, while the mechanisms directing the acute response of MPS activity 
to dietary protein have been well-characterized, the factors that determine the duration 
of the response are not well known. Therefore, Chapter IV will probe the ability of 
supplemental nutrients to influence the duration of protein-induced MPS activity when 
provided after a meal. Further consideration will be given to the energetic costs of MPS 
activity and the possibility that it accounts for a substantial proportion of diet induced 
thermogenesis (DIT). 
Chapter V highlights the major findings of this dissertation, addresses certain 
limitations, and offers direction for future research in light of results herein. 
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CHAPTER I: 
REVIEW OF LITERATURE 
 
INTRODUCTION 
 This dissertation aims to improve understanding of the role of dietary protein and 
the branched-chain amino acid leucine on body composition, energy partitioning, and 
cellular energetics. The purpose of Chapter I is to present a brief review of the pertinent 
literature on these topics.  
 
SKELETAL MUSCLE AND BODY COMPOSITION 
Skeletal muscle contributes substantially to lean mass and overall body 
composition, as it makes up ~42% of the average adult male’s body mass and ~36% of 
the average adult female’s body mass (45). Muscle is essential for critical activities such 
as locomotion, food gathering, and reproduction in all mammals, as well as for 
discretionary human activities such as physical labor and athletics (83). Properly 
functioning muscle contributes to quality-of-life across all life stages (73), and it is 
particularly important for functional capacity in aging or elderly populations. Healthy 
skeletal muscle allows for performance of activities of daily living including cooking, 
shopping, use of transportation, house chores, and money management, which 
generally reflect the competence for independent living (38).  
In healthy young adults, muscle protein synthesis and degradation are equally 
balanced, resulting in no net change in skeletal muscle mass (77). However, adults 
beyond the age of 50 (and perhaps earlier) suffer from an age-related loss of skeletal 
muscle mass at the rate of 1-2% per year (63). In 1989, this process was coined with 
the term sarcopenia – which comes from the Greek language – meaning “loss of flesh” 
(59). It has numerous contributors to its pathogenesis, including impaired muscle 
anabolism (17), lesser influence of growth and steroid hormones (13), as well as 
physical inactivity and poor nutrition (11). Sarcopenia limits the ability to complete 
activities-of-daily living in otherwise healthy older men and women (31), and low muscle 
mass is predictive of mortality in the elderly (70+ years) (10). 
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A potentially devastating condition involves an increase in fat mass concomitant 
with age-related muscle loss, which is known as sarcopenic obesity (60). Obesity in 
combination with low muscle strength leads to increased risk for poor mobility and 
functional decline, resulting in greater disability and health burden (75). Individuals with 
sarcopenic obesity are 2-3 times more likely to suffer disability of activities-of-daily living 
than those with lean sarcopenia (67). Recent research suggests that the inflammatory 
state associated with obesity can accelerate muscle catabolism, resulting in a vicious 
cycle that exacerbates sarcopenia, coupled with reduced physical activity and additional 
weight gain in the form of adipose (62). Consequently, there is clear need for 
approaches to attempt to prevent or combat the onset of sarcopenia and sarcopenic 
obesity. 
 
SKELETAL MUSCLE AND ENERGY EXPENDITURE 
The processes that consume energy in the human body can be divided into three 
components: basal metabolic rate, physical activity, and dietary thermogenesis. Basal 
metabolic rate, which includes all metabolic and transport activities required for bodily 
function at rest, makes up ~70% of total energy consumption. Physical activity 
consumes ~20% of total expended energy, while thermogenesis makes up the 
remaining ~10%. Skeletal muscle metabolism accounts for ~20% of the basal metabolic 
rate, or ~14% of total resting energy expenditure in the average adult (46). Energy 
expenditure varies among people independent of body size, and individuals with a “slow 
metabolism” are at an apparent greater risk for weight gain, which may be indicative of 
reduced energy expenditure by muscle. Early research demonstrated that 
approximately half of the variance in resting metabolic rate among individuals can be 
explained by resting metabolism in skeletal muscle (85). It is evident that modulation of 
skeletal muscle mass or its energy consumption can have an impact on total energy 
expenditure independent of physical activity or diet. Indeed, pharmacologic targeting of 
muscular energy expenditure has been proposed as a method to combat obesity (12).  
Dulloo et al. have recently elaborated on a premise regarding skeletal muscle’s 
fundamental contribution to whole-body thermogenesis and energy expenditure (19-21). 
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They have collected data indicating that, in conditions where skeletal muscle is 
appropriately sensitive to insulin, there exists a futile energy-dissipating cycle between 
de novo lipogenesis and lipid oxidation in muscle. In this scheme, synthesis of one 
molecule of palmitate from acetyl-CoA followed by its subsequent oxidation back to 
acetyl-CoA would consume 14 ATP molecules; therefore, repeated cycling of substrate 
in this manner would increase thermogenesis as well as provide a sink for glucose or 
lipid disposal in muscle. However, in conditions of insulin insensitivity and / or increased 
adiposity, this cycle is interrupted, thereby reducing muscular and whole-body energy 
expenditure. These studies suggest that optimizing skeletal muscle mass would not only 
increase overall thermogenesis, but could potentially draw energy substrate away from 
adipose storage and improve body composition. 
 
DIETARY PROTEIN AND BODY COMPOSITION 
It is widely held that total energy intake is the most important factor in 
determining body composition and weight management (56), but the independent 
influence of macronutrient proportions of the diet is controversial (22). Nonetheless, 
numerous clinical trials have provided evidence that increased dietary protein can 
positively influence body composition, promote retention of lean mass, and accelerate 
loss of fat mass during weight loss (37, 39, 41, 42, 44, 47). These effects are often 
attributed to the higher satiating effect of protein (28) or to the stronger influence that 
protein exerts on dietary thermogenesis (32). However, it has become evident that 
macronutrients not only provide energy, but that certain components can function as 
signaling molecules to regulate numerous physiological processes (81), including 
feeding behavior, efficiency of metabolism, overall energy balance (84), and in particular 
for the purposes of this dissertation – protein turnover in muscle.  
 
LEUCINE AND MUSCLE PROTEIN SYNTHESIS 
Leucine is one of the three branched-chain amino acids (with isoleucine and 
valine), and as an essential amino acid it must be consumed in the diet for good health. 
It is unique among all dietary amino acids in its ability to directly stimulate muscle 
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protein synthesis (MPS), and it seems to act as an indicator that there is an adequate 
supply of nutrients for protein synthesis to occur (24). Leucine increases activity of 
mammalian target of rapamycin (mTOR), a serine / threonine kinase, which activates 
downstream translation initiation factors such as 70-kDa ribosomal protein S6 kinase 
(p70S6K) and eukaryotic initiation factor 4E- binding protein1 (4E-BP1) (4). Activation of 
these initiation factors promotes assembly of the eiF4F complex, which is required for 
RNA binding to the ribosome and allows for protein synthesis to proceed (3).  
Lynch et al. found that drinking water supplemented with leucine resulted in 
greater protein synthetic activity in skeletal muscle, adipose, and liver after 12 d in rats 
(43). Similarly, deletion of branched-chain amino acid transferase (BCAT), the first 
enzyme in leucine catabolism, resulted in a 10-fold elevation in the plasma leucine 
concentration of mice (64). This was associated with a significant elevation of protein 
synthetic activity in skeletal muscle, heart, kidney, and adipose. Although the capacity 
for leucine to stimulate protein synthesis in multiple tissues has been demonstrated, 
much attention has been directed toward skeletal muscle and the potential to affect 
muscle mass. It is evident that leucine administration activates MPS in both animals 
(35) and in humans (18). However, the acute response lasts < 3 hrs (5), and the chronic 
response to leucine-induced MPS is not known. As previously mentioned, numerous 
reports have shown that elevated dietary protein, which is generally enriched in leucine, 
promotes maintenance or addition of lean tissue over time. This effect is frequently 
attributed in part to increases in MPS, but the causal link has not been appropriately 
established. 
 
DIETARY LEUCINE AND BODY COMPOSITION 
 The aforementioned BCAT null mice had 10-fold higher plasma leucine than wild-
type mice, and exhibited a comparatively lean phenotype. This was associated with 
elevated energy expenditure, which the authors attributed to a futile cycle of protein 
turnover (64); however, these outcomes are not generalizable among normal 
physiologies.  
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Investigators have supplemented drinking water with leucine to evaluate potential 
effects on body composition. Mice that consumed twice the amount of leucine as control 
mice gained less fat and body weight when fed a high-fat diet for 15 wks (84), while rats 
provided supplemental leucine lost significantly more body fat when submitted to 50% 
caloric restriction for 6 wks (16). However, another research group found that 
supplemental leucine or mixed branched-chain amino acids (BCAAs) had no effect on 
the body composition of mice fed a high-fat diet for 14 wks. These studies are limited by 
the use of free access to leucine-containing drinking water, which introduces variance in 
dosing. As such, there is a need for dosing strategies that standardize leucine 
consumption in order to appropriately assess body compositional effects in animal 
models.   
 Few studies have directly investigated the effect of dietary leucine on body 
composition in humans. Competitive wrestlers undergoing moderate caloric restriction 
that consumed a BCAA-supplemented diet lost the most body weight and body fat over 
19 d compared to those consuming a high-protein or low-protein diet (49). More broadly, 
a cross-sectional epidemiological study among 4400+ healthy, middle-aged adults from 
China, Japan, the United Kingdom, and the United States found that higher BCAA 
intake is associated with a lower prevalence of overweight and obesity (55). Future 
population-level analyses will be useful to better encapsulate the impact of dietary 
leucine on body composition.  
Conversely, two observational studies have noted elevations of plasma BCAAs 
(including leucine) in obese conditions. Plasma leucine was restored from significantly 
elevated levels in obese individuals following gastric bypass surgery, which coincided 
with an increased capacity for leucine oxidation by adipose tissue (65). The second 
study evaluated metabolomic profiles of lean vs. obese individuals utilizing principal 
component analysis, which identified a correlation between insulin resistance and 
BCAA-associated metabolites (50). The authors suggested that in the context of 
overnutrition, dietary BCAAs contribute to insulin resistance; however, this hypothesis 
cannot be differentiated from the potential for BCAA metabolism to be deranged in a 
pathological state of obesity, particularly in light of a recent study suggesting that 
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adipose tissue is more active in BCAA oxidation than was previously believed (30). At 
present, there is not enough data to form a consensus view on how dietary leucine 
impacts body composition. 
 
DIETARY PROTEIN AND THERMOGENESIS 
Post-meal dietary thermogenesis, also known as diet-induced thermogenesis 
(DIT) or the thermic effect of food, consumes ~10% of total energy expenditure at rest. 
This obligatory component of energy expenditure is required for the proper absorption, 
digestion, and conversion of nutrients into their respective storage forms, such as 
glycogen or triglyceride (32), and ~90% of DIT occurs within 6 hrs of meal consumption 
(57). It has long been known that among macronutrients, protein contributes the 
greatest thermic effect of food (23); estimates based on analysis of metabolic pathways 
indicate that 20-30% of energy contained within a typical protein is lost to 
thermogenesis, while 5-10% and 0-3% of energy are lost from carbohydrate and fat, 
respectively (1). Once a dietary protein is digested into its component amino acids, the 
amino group must be removed by transamination or deamination, and disposed of via 
the urea cycle, which accounts for much of the additional energetic cost of catabolism.  
 There are numerous studies demonstrating that protein exerts the strongest 
influence on DIT among macronutrients. For example, post-prandial thermogenesis 
after consumption of a high-protein, low-fat meal was greater after consumption of a 
high-carbohydrate, low-fat meal in young, healthy women (33) and men (58). Post-
prandial lipid oxidation and associated energy expenditure following a 30% protein meal 
was greater independent of BMI than that following a 15% protein meal (36), and 
similarly, consumption in a sealed metabolic chamber of a 30% protein diet resulted in 
greater DIT and 24 hr energy expenditure than consumption of a 10% protein diet (40). 
Conversely, reduced postprandial energy expenditure and increased exogenous fat 
oxidation was observed in young women after ingestion of test meals with low protein 
content compared to adequate protein content (52). 
 A regression analysis of 19 studies that compared the magnitude of DIT to the 
macronutrient composition of the test food found that a 1% increase in the protein 
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fraction resulted in a DIT increase of 0.2%, while no such influence was identified from 
the carbohydrate or fat components (78). Westerterp and others (79, 81) suggest that 
protein-induced thermogenesis can positively influence body temperature and lead to 
feelings of satiety independent of hormonal influence, thereby contributing to protein’s 
greater satiating effect relative to fat and carbohydrate. This satiating effect is believed 
to contribute to protein’s positive effect on energy balance (80).  
A meta-analysis of studies comparing DIT among lean and obese adult 
populations found that in 22 of 29 trials, DIT was significantly lower in the obese, which 
the authors associated with the level of insulin resistance (15). This is in agreement with 
the previously mentioned work by Dulloo suggesting that insulin insensitivity contributes 
to a decline in thermogenesis by muscle (19). Therefore, it would be advantageous to 
utilize strategies that improve insulin sensitivity of muscle in combination with optimizing 
skeletal muscle mass in order to maximize the thermogenic capacity of muscle and to 
increase resting energy expenditure.  
  Recent research has evaluated the impact of different dietary proteins on 
thermogenesis. Tan et al. failed to find differential effects on 8 hr energy expenditure or 
lipid oxidation following consumption of isocaloric, 30% protein meals containing either 
meat, dairy, or soy protein (70), while another study found that consumption of 
isocaloric, isonitrogenous meals containing animal (pork) protein resulted in a 2% 
greater 24 hr energy expenditure when compared to meals containing vegetable (soy) 
protein (48). Most recently, energy expenditure in healthy adults was measured 5.5 hrs 
after consumption of an isocaloric meal containing 50% protein from soy, casein, or 
whey; the thermic effect from the whey protein was significantly greater than that of the 
soy or casein proteins despite equal protein content (2). 
There is mounting evidence that protein’s positive impact on thermogenesis may 
be due to its ability to stimulate protein synthesis. Giordano et al. evaluated infusions of 
increasing whole amino acid mixtures on DIT, finding that the absolute rise in energy 
expenditure was dose-responsive, and that it was positively associated with the ability 
of the amino acids to acutely stimulate protein synthesis (25). A similar study in rats 
found that intravenous administration of an amino acid mixture stimulated protein 
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synthesis in muscle and elevated core body temperature (82). These findings suggest 
that DIT may be determined in part by dietary protein’s ability to stimulate protein 
synthesis, and furthermore by the ability of a particular protein source to stimulate 
protein synthesis. However, the mechanisms by which this might occur require further 
investigation.  
 
LEUCINE AND MITOCHONDRIA 
 The mitochondrion is the primary energy-producing organelle of most tissues and 
cell types (76). Skeletal muscle has the ability to adapt to a variety of environmental 
stresses, such as cold exposure, caloric restriction, and exercise by modulating the 
size, number, and mass of mitochondria in a process known as mitochondrial 
biogenesis (74). In all cases, this process is mediated by the activity of peroxisome 
proliferator activated receptor γ coactivator 1α (PGC-1α), a “master co-regulator” that 
influences gene expression patterns involving multiple aspects of metabolism (54).  
Cultured C2C12 myocytes incubated with leucine increased lipid oxidation in vitro 
(68), and subsequent leucine treatment at a concentration meant to mimic that of a high 
protein meal increased oxygen consumption and stimulated mitochondrial biogenesis, 
including induction of PGC-1α (69). In support of this finding, two animal studies indicate 
that dietary leucine can affect mitochondria in vivo. Guo et al. provided 1.5% leucine in 
drinking water to diabetic mice for 8 mos, which induced expression of a series of genes 
involved in effecting mitochondrial biogenesis (27). These animals expended 10% more 
energy than control animals, despite equal physical activity. D’antona et al. added 
BCAAs to drinking water of middle-aged mice at 1.5 mg / g body weight per day for the 
duration of the lifespan, which stimulated both the transcription and expression of 
numerous genes of mitochondrial biogenesis, and increased endurance capacity to 
treadmill running (14). These findings indicate that leucine may have a direct or indirect 
effect on muscle’s ability to oxidize substrate and produce ATP, and it is reasonable to 
suspect that this is in response to an additional demand for energy to support leucine-
induced protein synthetic activity. 
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Consumption of a meal supplemented with leucine was able to stimulate 
mitochondrial protein synthesis in addition to sarcoplasmic protein synthesis in both 
young and old rats (26), indicating that leucine-induced MPS activity has the potential to 
affect mitochondrial content. Mitochondrial function declines in the elderly due to 
cumulative oxidative damage of mitochondrial DNA (mtDNA), resulting in a reduction of 
the mitochondrial ATP production rate (66). These changes are likely determinants of 
the reduced oxidative capacity and functional decrement in aging muscle. An 8 hr 
infusion of BCAAs increased mitochondrial ATP production rate in young, but not elderly 
individuals (71). The authors did not measure MPS, but speculated its activity was 
perhaps related to the enhancement of mitochondrial ATP production in the young 
group. Elderly people become less sensitive to leucine-induced MPS activity than young 
adults (51), which suggests that Tatpati et al. may have observed an effect on 
mitochondrial ATP production in the elderly if a larger dose of leucine was utilized. It is 
similarly possible that the age-related decline in mitochondrial function is affected by a 
reduced ability of muscle to respond to leucine. Further research is required to 
determine how leucine can positively impact mitochondria in skeletal muscle. 
 
CELLULAR ENERGETICS AND PROTEIN SYNTHESIS 
 In order for a cell to function properly, it requires a constant supply of biological 
energy to meet the demands of its most vital processes. This requirement is mediated 
by the actions of 5’ adenosine monophosphate-activated protein kinase (AMPK), which 
is the key sensor of cellular energy in all tissues (34). AMPK is sensitive to the 
concentration of adenosine monophosphate (AMP), which is liberated from hydrolysis of 
adenosine triphosphate (ATP) during energy consumption. AMPK acts as a signaling 
kinase to coordinate the activity of anabolic (energy-consuming) and catabolic (energy-
liberating) processes. In conditions where cellular energy availability is low, the AMP / 
ATP ratio becomes elevated, increasing AMPK activity and resulting in a shift towards 
catabolism. When a surfeit of cellular energy exists, the AMP / ATP ratio is relatively low 
and anabolism is favored (29).  
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 Protein synthesis is an anabolic process that requires substantial amounts of 
energy; it has been estimated that 30-50% of all cellular energy is consumed by the 
process (7). The majority of this energy is utilized for translation elongation, which is the 
process of adding single amino acids to a nascent polypeptide. Four high-energy bonds 
(2 from ATP and 2 from GTP) are hydrolyzed for each amino acid added to a peptide 
chain (8). It is therefore logical that translation elongation activity would be dampened 
when cellular energy is limited. Translation elongation is regulated primarily via 
eukaryotic elongation factor 2 (eEF2), which inhibits elongation when it is in a 
phosphorylated state (8). eEF2 is phosphorylated by eEF2 kinase (9) and perhaps other 
signaling kinases, but its regulation is not well understood. Nonetheless, AMPK has 
been shown to activate eEF2 kinase and therefore activate eEF2 in vitro (7). This 
provides a potential link by which energy depletion could limit protein synthesis. 
 The AMP analogue 5-aminoimidazole-4-carboxamide 1-beta-d-ribonucleoside 
(AICAR) is frequently used to artificially stimulate AMPK activity. The first indication that 
AMPK could regulate protein synthesis came from injection of rats with AICAR, which 
resulted in a 50% decrement in MPS activity (6). This was elaborated upon by studies 
demonstrating that AICAR (and thus elevated AMPK activity) sufficiently abolished 
induction of MPS by leucine (53) and electrical stimulation (72). Most recently, 
incubation of rat muscle fibers with leucine reduced AMPK activity and stimulated MPS, 
while co-incubation with AICAR prevented the effect (61). These data suggest that 
AMPK functions to suppress MPS activity, thereby conserving ATP during conditions of 
energy deficit. Nonetheless, the threshold of the response and its timing in response to 
nutrients needs to be further elucidated. 
 
SUMMARY 
Improvements in the amount and quality of skeletal muscle provide clear benefits 
throughout adult life. Clinical trials indicate that elevated dietary protein promotes 
favorable body composition, including retention or accretion of muscle mass and 
reduction of fat mass. This effect may in part be attributed to leucine’s effect on protein 
synthesis in muscle, although the association has not been appropriately established. 
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Sufficient dietary leucine acutely stimulates MPS, but the chronic effects of dietary 
leucine on body composition and energy are not well characterized. Additional 
investigation into the energetic demands of protein turnover in muscle may provide 
insight into the means by which increased dietary protein promotes favorable health 
outcomes. 
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CHAPTER II: 
METABOLIC RESPONSES TO DIETS REPRESENTING THE UPPER AND LOWER 
ENDS OF THE ACCEPTABLE MACRONUTRIENT DISTRIBUTION RANGE BECOME 
LESS FAVORABLE AS THE DIETARY CARBOHYDRATE / PROTEIN RATIO 
INCREASES 
 
INTRODUCTION 
The current Dietary Guidelines for Americans state that management of a healthy 
weight is a key factor in reducing risk for Type 2 Diabetes in adults (34), and further they 
endorse the USDA Food Patterns and the Dietary Approaches to Stop Hypertension 
(DASH) Eating Plan as model dietary patterns to accomplish this goal. These guidelines 
place emphasis on nutrient-rich food selections in part by limiting inclusion of added 
sugars, although they do not restrict amounts of non-sugar carbohydrate sources, per 
se. With regard to macronutrient composition, these patterns are constrained only to 
comply with the Acceptable Macronutrient Distribution Range (AMDR) of the Dietary 
Reference Intakes (DRI). The AMDR permits consumption of 45-65% of calories as 
carbohydrate, 10-35% of calories as protein, and 20-35% of calories as fat (33), which 
allows for myriad combinations of macronutrients within a dietary pattern that are 
compliant to the recommendation. However, with regards to weight management, the 
Dietary Guidelines state that the relative macronutrient proportions of a dietary pattern 
are not a critical factor. This approach disregards the potential for metabolic responses 
to vary among different diet patterns.  
Recommendations from the USDA Food Patterns and the DASH diet typically 
result in consumption of carbohydrate and protein at the high and low ends of their 
AMDRs, respectively (9), which results in a dietary carbohydrate / protein ratio > 3. 
Conversely, diets with a reduced carbohydrate / protein ratio (≤ 1.5) have gained 
increasing approval, and have been shown in clinical trials to improve glycemic 
regulation, insulin homeostasis, body composition, and cardiovascular disease risk 
during weight loss (11, 22, 23, 25). There has been limited research focused on how 
metabolic responses to meals differ across the AMDR for macronutrient compositions. 
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Typical management for individuals with Type 2 Diabetes focuses on control of 
fasted glucose and chronic biomarkers such as glycated hemoglobin (HbA1c), but 
therapies targeting these measures may not positively affect mortality or incidence of 
co-morbidities (1). However, there is increasing evidence that post-prandial glucose and 
/ or comparison to fasted glucose may better encapsulate the metabolic fitness of and 
individual and lead to better prevention and treatment strategies. A recent investigation 
suggests that post-prandial glucose may be a better index of glycemic regulation than 
fasting plasma glucose (13). Post-prandial hyperinsulinemia can induce or exacerbate 
post-prandial hypertriglyceridemia (17), and limiting the magnitude of post-prandial 
glucose excursions can reduce the risk of cardiovascular disease (12, 16). As such, 
dietary strategies that moderate carbohydrate intakes merit evaluation, since dietary 
carbohydrate is the major determinant of post-prandial glucose (2).  
Separately, increases in post-prandial plasma amino acids (particularly the 
branched chain amino acid leucine) predict the degree of protein synthesis stimulation 
in skeletal muscle following consumption of a meal (27). This information supports the 
assertion that the macronutrient content of a diet influences the post-prandial plasma 
milieu and the subsequent physiologic responses. Previous work from our laboratory 
has shown that reduction of the dietary carbohydrate / protein ratio within the 
acceptable ranges of the DRI attenuates post-prandial glucose and insulin levels, 
reduces PI3K / Akt activation and subsequent glucose uptake by adipose (5), and 
increases insulin sensitivity by skeletal muscle at the expense of adipose (10) in rats. As 
such, there appears to be different metabolic regulation of glycemia in response to 
meals that differ in carbohydrate (and protein) content.   
The purpose of this study was to further evaluate the metabolic and whole body 
responses to diets across three different carbohydrate / protein ratios in normal, non-
diabetic adult rats. Previous results have shown that elevated carbohydrate diets exert a 
stronger influence on peripheral insulin signaling (3). It is of interest to determine if the 
related elevations in post-prandial glucose and insulin have any differential impact on 
metabolism in liver, as well as skeletal muscle and adipose. We hypothesized that as 
the carbohydrate / protein ratio increased, post-prandial hyperinsulinemia would dictate 
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a greater reliance on peripheral insulin signaling, and that enhanced glucose uptake by 
adipose would result in greater adiposity. The present study utilized a meal feeding 
model in normal, non-diabetic adult rats to determine chronic responses (25 d) to diets 
with different carbohydrate / protein ratios in order to evaluate responses in post-
prandial insulin, peripheral insulin signaling, capacity for lipid synthesis, hepatic 
integrated stress response, and body composition.   
 
METHODS 
Animals. Forty-eight male Sprague-Dawley rats (Harlan-Teklad, Indianapolis, IN) 
with a mean body weight of 166 ± 7 g were housed individually in stainless steel wire-
bottomed cages and maintained at 24°C with a 12 h reverse light cycle (light: 1900-
0700 h) and free access to water. The animal protocol was approved by the University 
of Illinois Institutional Animal Care and Use Committee. 
Rats were trained to consume three meals each day to mimic human eating 
patterns (4). The meal pattern consisted of a 3 g morning meal consumed between 
0700-0720 h followed by free access to food between 1300-1400h and 1800-1900 h. 
The meals consisted of a powdered, modified AIN-93M diet (Table 2.1). The rats 
adapted to this pattern within two days, resuming normal food intake and growth.  
On day three, rats were randomized to consume one of three isocaloric treatment 
diets (n = 16 per group): high carbohydrate-low protein (HCLP; 58% of energy from 
carbohydrate, 12% from protein, and 30% from fat), moderate carbohydrate-moderate 
protein (MCMP; 40% of energy from carbohydrate, 30% from protein, and 30% from 
fat), or low carbohydrate-high protein (LCHP; 25% energy from carbohydrate, 45% from 
protein, and 30% from fat). The carbohydrate / protein ratios of the diets were 4.8, 1.33, 
and 0.6, respectively. The net metabolizable glucose load of the diets was determined 
by adding ½ the sucrose weight to the maltodextrin weight. Diet compositions are 
presented in Table 2.1. Rats consumed their respective treatment diets for 25 d, while 
measurements of food intake and body weight recorded for the duration of the study.  
On day twenty-five, rats from each treatment group (n = 8) were deprived from 
food for 12 h and then either euthanized by decapitation (food deprived) or fed their 
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normal 3 g morning meal. Ninety minutes after consumption of the meal, rats were 
euthanized by decapitation and blood and tissues were harvested. Trunk blood was 
collected in EDTA tubes to prevent clotting and immediately immersed in ice. Blood was 
centrifuged at 1800 x g for 20 min. at 4°C and plasma was separated and stored at -
80°C until analysis. Tissues, including gastrocnemius, plantaris, and soleus muscle, 
renal and epididymal fat pads, and liver, were weighed prior to being snap frozen in 
liquid nitrogen and stored at -80°C for later analyses. 
Plasma measurements. Plasma insulin concentrations were determined using a 
commercial RIA kit for rat insulin (Linco Research, MO). Plasma glucose was 
determined by glucose oxidase method (ThermoTrace, Victoria AUS). 
Tissue homogenization. Gastrocnemius and epididymal fat were pulverized in 
liquid nitrogen prior to homogenization. 100 mg of muscle tissue was homogenized in 2 
mL ice cold lysis buffer (20 mM HEPES ph 7.2, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 
1x HALT Protease Inhibitor (Pierce, Rockford, IL), 1x HALT Phosphatase Inhibitor 
(sodium fluoride, sodium orthovanadate, sodium pyrophosphate; Pierce, Rockford, IL), 
and 2mM phenylmethylsulfonyl fluoride. 200 mg adipose tissue was homogenized in 0.7 
mL ice cold lysis buffer (40 mM HEPES pH 7.4, 4 mM EGTA, 100 mM NaF, 50 mM KCl, 
0.4 mM EDTA, 100 mM B-glycerophosphate, 0.4g CHAPS/ 100 mL buffer, 1% Triton X-
100, 1x HALT Protease Inhibitor, 1x HALT Phosphatase Inhibitor, and 2mM 
phenylmethylsulfonyl fluoride. Samples were centrifuged at 10,000 x g for 10 min at 4°C 
to concentrate protein in the supernatant. Total protein was determined using the 
bicinchoninic acid method. 
Akt and p70S6 kinase activity. Whole cell lysates were separated by SDS-PAGE, 
and then transferred to nitrocellulose membranes for immunoblotting. After blocking in 
SuperBlock T20 (Pierce), membranes were incubated with either rabbit polyclonal Akt 
antibody (Cell Signaling, Danvers, MA) diluted 1:1000, rabbit polyclonal Ser473 phospho-
Akt antibody (Cell Signaling) diluted 1:1000, or affinity purified rabbit p70S6K antibody 
(Bethyl Laboratories, Montgomery, TX) diluted 1:1500 overnight at 4°C. Antigen was 
detected by enhanced chemiluminesence (GE, Piscataway, NJ), and exposure / 
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quantification was conducted using a Kodak Imaging Station 440 CF (Eastman Kodak 
Co., Rochester, NY). 
Gene expression. Total RNA was isolated from ~50 mg frozen liver tissue or 
~100mg frozen epididymal fat using TRI Reagent® (Sigma-Aldrich, St. Louis, MO). First-
strand cDNA was synthesized using random hexamers on a thermal cycler. RT-PCR 
was run with 7.5 ng of cDNA template and oligonucleotide primers designed to amplify 
fatty acid synthetase or sterol regulatory element-binding protein 1c (SREBP-1c) in liver 
or adipose. All primers were obtained from IDT (Coralville, IA). The relative abundance 
of each gene was normalized to expression of the L7a control gene. 
Statistical analysis. Data are expressed as mean ± SEM. All variables were 
evaluated for normality and homogeneity of variance by Levene’s test. Percent change 
comparisons were made by subtracting the mean fasted value from post-prandial 
values. A one-way ANOVA was performed with the dietary treatment as the 
independent variable. When a significant effect was detected, differences among means 
were determined using an LSD post hoc test or a Games-Howell post hoc test when 
variances were not equal. Correlations were assessed by Pearson’s linear regression. 
The level of significance was set at P < 0.05. All analyses were performed using SPSS 
Version 15.0 (Chicago, IL). 
 
RESULTS 
Food intake. Mean daily food intake was lower for the LCHP group (13.96 ± 0.26 
g / d) than the MCMP (15.22 ± 0.21 g / d; p < 0.01) and HCLP (15.61 ± 0.33 g / d; p < 
0.01) groups. 
Body and tissue weights. After 25 d of feeding, the HCLP group had the lowest 
body weight, while the MCMP group was the heaviest, and the body weight of the LCHP 
group was intermediate between the two (Table 2.2). The LCHP and MCMP groups had 
heavier livers than the HCLP group. The HCLP had lower total (gastrocnemius + 
plantaris + soleus) muscle weight than the MCMP and LCHP groups, and the HCLP had 
greater total (renal + epididymal) adipose weight than the MCMP and LCHP groups. 
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Plasma measurements. Fasted plasma glucose and insulin were not different 
among treatments (Table 2.3). When expressed as a percent change from the fasted 
condition, the post-prandial insulin rise was greater in MCMP and HCLP than in LCHP 
(Figure 2.1). 
  Liver measurements. There were no effects of diet treatment on fasted hepatic 
FAS expression (Table 2.3), while post-prandial hepatic FAS was higher in MCMP and 
HCLP than LCHP (Figure 2.2). Overall, there were positive correlations of hepatic FAS 
expression with the carbohydrate content of the diet (r = 0.377; p = 0.011) and with the 
glucose load of the diet (r = 0.339; p = 0.023). In the fasted condition, hepatic SREBP1c 
expression was higher in the LCHP group than in the MCMP and HCLP groups (Table 
2.3). When expressed as a percent change from the fasted condition, the increase in 
hepatic SREBP1c in the HCLP group was significantly greater than that of the LCHP 
group, while the respective increase in the MCMP group was intermediate (Figure 2.3).  
Hepatic ATF3 expression in the fasted state was higher in the HCLP group than 
in the LCHP and MCMP groups (Table 2.3). Overall, there were positive associations of 
hepatic ATF3 expression with the carbohydrate content of the diet (r = 0.380; p = 0.009) 
and with the glucose load of the diet (r = 0.373; p= 0.011). Asparagine synthetase 
expression in liver was not different in the LCHP and MCMP groups in either the fasted 
or fed condition. However, expression levels in HCLP were ~50 times greater in the 
fasted state and ~15 times greater in the fed state than in the other two groups (Figure 
2.4). Overall, there was a positive association of asparagine synthetase expression with 
the carbohydrate content of the diet (r = 0.613; p < 0.001) and with the glucose load of 
the diet (r = 0.587; p < 0.001). 
 Adipose measurements. In the fasted state, adipose expression of FAS in the 
LCHP group was higher than in the HCLP group, while the expression level of the 
MCMP group was intermediate between the two (Table 2.3). When expressed as a 
percent change from the fasted condition, the FAS expression increase in the HCLP 
group was greater than for the LCHP group, while the respective increase of the MCMP 
group was intermediate (Figure 2.5). No significant group differences were found in 
SREBP1c expression in adipose (Table 2.3), although there was trend for a significant 
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association of adipose SREBP1c expression with the glucose load of the diet (r = 0.265; 
p = 0.090). 
There was no group treatment effect on Akt activity in adipose (Table 2.3). 
However, in the fasted condition, p70S6K activity was higher in the HCLP group than in 
the LCHP group, with the MCMP group intermediate (Table 2.3).  
Skeletal muscle measurements. There were no group differences in fasted Akt 
activity (Table 2.3). However, when expressed as a percent change from the fasted 
condition, the rise in Akt activity in the LCHP group was significantly different from the 
decrease in Akt activity in the HCLP group, while the MCMP group was intermediate 
(Figure 2.6). Overall, there was a trend for a negative association of Akt activity with the 
carbohydrate content of the diet (r = -0.268; p = 0.063) and a significant negative 
association of Akt activity with the glucose content of the diet (r = -0.315; p = 0.027). 
There were no effects of diet treatment on p70S6K activity (Table 2.3).  
 
DISCUSSION 
 The present study utilized a meal feeding protocol in normal, non-diabetic adult 
rats to determine chronic responses (25 d) to diets with different carbohydrate / protein 
ratios to evaluate metabolic responses in glycemia, peripheral insulin signaling, capacity 
for lipid synthesis, and body composition. The primary findings from this research were 
the post-prandial and metabolic responses to consumption of whole meals were least 
desirable in the high carbohydrate / low protein condition, including activation of the 
integrative stress response in liver that is indicative of marginal protein deficiency and 
increased endogenous fatty acid synthesis.  
Use of a discrete meal feeding protocol versus conventional ad libitum feeding 
was employed to study post-prandial responses and examine metabolic flexibility when 
the body is displaced from metabolic homeostasis of the fasting period. Previous 
research using similar treatments has shown that high-carbohydrate diets demand an 
increased reliance on insulin-mediated glucose disposal (4). In the current study, across 
a wide range of carbohydrate intakes, plasma glucose was similar in all conditions 
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reflecting a substantial capacity to maintain glucose homeostasis. However, there were 
divergent metabolic responses related to achieving glycemic control. 
 The liver can respond to nutrient excess by converting carbohydrates into lipids 
via de novo lipogenesis. Physiological levels of carbohydrate and insulin are known to 
influence fatty acid synthetase (FAS) (32) and SREBP-1c (14), two key genes 
implicated in lipogenesis by liver and adipose. The capacity for hepatic lipid synthesis 
was evaluated by the relative expression of FAS and SREBP1c. FAS is responsive to 
insulin concentrations as well as dietary carbohydrate (21), while SREBP1c can be 
induced by insulin (28). As dietary carbohydrate (and dietary glucose load) increased, 
the hepatic capacity for lipid synthesis increased, as post-prandial FAS expression was 
greater in MCMP and HCLP than in LCHP. The rise in hepatic SREBP1c expression 
from fasted to fed conditions was greater with increasing carbohydrate and highest in 
the HCLP group.  
While the meal response of FAS and SREBP1c was in proportion to the 
carbohydrate content of the meal, baseline SREBP1c expression in the fasted condition 
was highest in LCHP. It has been demonstrated that hepatic SREBP1c can be 
positively regulated by S6 kinase 1, which is a downstream effector of mammalian 
target of rapamycin (mTOR) (24). A similar high-protein diet was shown to activate 
hepatic mTOR (8), so it is possible that hepatic mTOR stimulation lead to increased 
basal SREBP1c expression. Nonetheless, the post-prandial response of SREBP1c was 
greater in magnitude with increasing carbohydrate and the corresponding rise in insulin, 
and hepatic SREBP1c is most responsive to refeeding and insulin levels (18). These 
results suggest that high dietary carbohydrate exceeds the amount of glucose that can 
be utilized as energy or stored as glycogen during the absorptive period, which requires 
shunting of the excess carbohydrate into lipid synthesis.  
Similarly, in adipose high dietary carbohydrate resulted in a greater post-prandial 
elevation in expression of FAS, and there was a trend for SREBP1c expression to be 
greater with increasing dietary glucose load. This suggests that energy in the form of 
carbohydrate is increasingly taken up by adipose, which is subsequently utilized as 
substrate to synthesize lipids for energy storage. 
26 
 
Consistent with the response in the insulin-sensitive hepatic lipogenic gene 
expression, there was a differential post-prandial insulin effect of the diets. Plasma 
glucose is elevated in response to a meal, and pancreatic insulin release directs 
peripheral uptake of glucose to maintain glucose concentrations in the appropriate 
range. Post-prandial insulin levels were higher in the MCMP and HCHP groups than the 
LCHP group, and the 288% elevation in post-prandial insulin from the fasted level in 
LCHP was significantly larger than the 40% elevation in LCHP (with response of MCMP 
intermediate). This large excursion of insulin in the higher carbohydrate-containing 
groups indicates an increased reliance on insulin-mediated peripheral uptake of glucose 
to maintain glycemia. The relatively lower insulin response in the LCHP group suggests 
a lesser reliance on insulin-mediated glucose disposal, and an increased ability for 
hepatic glucose regulation (26).  
The Dietary Reference Intakes (DRI) allow for consumption of protein as low as 
10% of total energy as adequate for good nutrition. However, the HCLP diet provided 
protein at 12% of total energy and produced an integrated stress response in liver 
reflecting an early adaptation to amino acid deficiency. The integrated stress response 
is a pro-survival gene expression program that promotes cell survival (19). A variety of 
different stressors such as viral infection, hypoxia, or amino acid deprivation can 
activate the pathway by phosphorylating eukaryotic initiation factor-2 (eIF2), which 
subsequently depresses cellular protein synthetic activity (29). General Control 
Nondepressible 2 (GCN2) is one of at least 4 different mammalian kinases that can 
phosphorylate eIF2, and it does so in response to amino acid deprivation (6). Likewise, 
conditions of amino acid deficiency induce the transcription factor ATF3 via GCN2, 
which subsequently induces elevates expression of asparagine synthetase (7). In the 
present study, hepatic ATF3 expression was elevated in the post-prandial condition by 
the HCLP diet, and there was an overall association of ATF3 expression with the 
carbohydrate content and glucose load of the diets. Asparagine synthetase expression 
was drastically induced in HCLP, while no such changes were seen in either LCHP or 
MCMP. Although not responsive to dietary carbohydrate, this pathway is activated in 
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response to amino acid deprivation, which suggests that the 12% protein diet that is 
largely comprised of carbohydrate may be marginally inadequate in amino acid supply.  
Circulating insulin activates a canonical signaling pathway in peripheral tissues, 
including skeletal muscle and adipose. Insulin interacts with a membrane-bound insulin 
receptor that autocatalyzes upon ligand binding, which in turn phosphorylates and 
activates insulin receptor substrate 1 (IRS-1). IRS-1 stimulates phosphoinositide 3-
kinase (PI3K) activity, which subsequently activates Akt / protein kinase B, a serine / 
threonine kinase. Active Akt stimulates glucose transport via GLUT4 translocation, 
glycogen synthesis via GSK-3β inhibition, and protein synthesis via p70S6 kinase 
activation (31). In the present study, as dietary carbohydrate intake increased, the post-
prandial plasma insulin concentration increased, but the insulin signaling response 
through Akt was depressed in skeletal muscle, and there was a trend for an inverse 
correlation between carbohydrate content of the diet and Akt activity reflecting insulin 
resistance with increasing carbohydrate exposure. These findings support the 
hypothesis that glucose mediates insulin resistance in muscle, but oppose the assertion 
that leucine is similarly implicated (30). Contrary to the response found in muscle, 
insulin signaling in adipose was elevated with increasing carbohydrate, as the HCLP 
group had the greatest basal p70S6K activity. These data suggest that as dietary 
carbohydrate increases, the insulin signal that induces skeletal muscle to take up 
glucose becomes weaker, while the insulin signal that induces adipose to take up 
glucose becomes stronger. The body composition results support the assertion that 
increased dietary carbohydrate would enhance the capacity for lipid synthesis and 
energy storage in adipose, as the HCLP had the largest fat pad weight and the lowest 
skeletal muscle weight. Conversely, the LCHP group had the smallest fat pad weight 
and the largest muscle weight. These data suggest that in high carbohydrate conditions, 
adipose increasingly becomes a depot for dietary carbohydrate, as de novo lipogenesis 
is stimulated in both liver and adipose. 
 The treatment diets were designed to vary the carbohydrate / protein ratio, and 
so when carbohydrate content of the diet was reduced, the protein content was 
accordingly increased. Dietary protein contributes carbon skeletons in the form of amino 
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acids for hepatic production of glucose, which contributes to liver-dependent regulation 
of glucose homeostasis (20). Additionally, dietary protein independently influences 
insulin signaling in skeletal muscle, without affecting glucose uptake (4). The 
contribution of the essential amino acid leucine from dietary protein has broad 
stimulatory effects on skeletal muscle protein synthesis (15), which will addressed in 
subsequent chapters. 
This study evaluated metabolic responses to 25 d of feeding diets with varied 
carbohydrate / protein ratios. Across all of the diets, the adult rats were able to produce 
metabolic adaptations to maintain glucose homeostasis; however, the metabolic 
outcomes were least desirable in the high carbohydrate with low protein condition. The 
HCLP diet was associated with an enhanced capacity for de novo lipogenesis in both 
liver and adipose. The integrated stress response was activated liver, indicating at least 
a marginal deficiency in dietary amino acids. Skeletal muscle became less responsive 
to insulin while adipose became more responsive, reflecting an apparent increased 
reliance of insulin-mediated uptake of carbohydrate by adipose. Furthermore, the HCLP 
diet resulted in smaller skeletal muscle mass and relatively larger adipose mass. When 
dietary carbohydrate was exchanged for protein, the carbohydrate / protein ratio was 
reduced, and generally these responses were reversed. The low carbohydrate diet was 
characterized by enhanced insulin sensitivity in skeletal muscle but not in adipose, a 
reduced capacity for de novo lipogenesis, and more favorable body composition with 
larger skeletal muscle mass and reduced adipose mass. In summary, the array of diets 
with respect to carbohydrate and protein can result in significantly different metabolic 
outcomes, and these outcomes appear most favorable when the ratio of carbohydrate / 
protein ratio is reduced. The long-term implications of these metabolic adaptations to 
life-long health and disease risk need to be determined. 
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Figure 2.1. Percent change of post-prandial plasma insulin from the fasted state in rats fed diets of 
different carbohydrate / protein ratios for 25 d. Data are means ± SEM; n = 6-8.  Labeled means without a 
common letter differ, P < 0.05. 
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 Figure 2.2. Hepatic FAS mRNA relative abundance in rats fed diets of different carbohydrate / protein 
ratios for 25 d. Data are means ± SEM; n = 6-8. Labeled means without a common letter differ, P < 0.05. 
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Figure 2.3. Percent change of post-prandial hepatic SREBP1c mRNA relative abundance from the fasted 
state in rats fed diets of different carbohydrate / protein ratios for 25 d. Data are means ± SEM; n = 6-8. 
Labeled means without a common letter differ, P < 0.05. 
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Figure 2.4. Hepatic asparagine synthetase mRNA relative abundance in rats fed diets of different 
carbohydrate / protein ratios for 25 d. Data are means ± SEM; n = 6-8. * indicates group difference among 
meal condition; ‡ indicates meal condition difference among group, P < 0.05. 
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Figure 2.5. Percent change of post-prandial adipose FAS mRNA relative abundance from the fasted state 
in rats fed diets of different carbohydrate / protein ratios for 25 d. Data are means ± SEM; n = 6-8. 
Labeled means without a common letter differ, P < 0.05. 
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 Figure 2.6. Percent change of skeletal muscle Akt % activation from the fasted state in rats fed diets of 
different carbohydrate / protein ratios for 25 d. Data are means ± SEM; n = 6-8. Labeled means without a 
common letter differ, P < 0.05.  
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Table 2.1. Diet composition for treatment groups 
Diet Component LCHP MCMP HCLP 
Casein 480.03 320.02 128.01 
L-cysteine 7.31 4.87 1.95 
Cornstarch 171.00 273.61 396.74 
Sucrose 56.75 90.80 131.66 
Maltodextrin 42.99 68.79 99.75 
Cellulose 50 50 50 
Soybean Oil 144.39 144.39 144.39 
Choline bitartrate 2.5 2.5 2.5 
Mineral mix 35 35 35 
Vitamin mix 10 10 10 
t-butylhydroquinone 0.014 0.014 0.014 
Net metabolizable glucose 71.635 114.19 165.58 
 
Grams per kg diet.  
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Table 2.2. Body and tissue weights after 25 d of feeding diets with different carbohydrate / 
protein ratios 
  LCHP MCMP HCLP 
Whole body (g) 297.5 ± 4.9ab 306.6 ± 3.6a 290.0 ± 3.7b 
Liver (g) 10.43 ± 0.30a 10.45 ± 0.26a 9.25 ± 0.28b 
Muscle total (g) 4.50 ± 0.07a 4.51 ± 0.08a 4.10 ± 0.4b 
Adipose total (g) 3.32 ± 0.24b 4.24 ± 0.21a 4.46 ± 0.30a 
 
Muscle total includes gastrocnemius, plantaris, and soleus. Adipose total includes epididymal and renal 
fat pads. Values represent means ± SEM; n=16. Different letters in a row indicate significant difference, P 
< 0.05. 
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Table 2.3. Fasted measurements after 25 d of feeding diets with different carbohydrate / protein 
ratios 
  LCHP MCMP HCLP 
Glucose (mmol / L) 10.62 ± 0.86 10.4 ± 0.34 12.17 ± 0.97 
Insulin (pmol / L) 106.1 ± 11.1  103.1 ± 20.6  85.5 ± 12.2  
Hepatic FAS (abundance) 3.76 ± 1.20  2.66 ± 0.69 7.08 ± 3.65 
Hepatic SREBP-1c (abundance) 1.71 ± 0.20a 1.27 ± 0.15ab 1.15 ± 0.16b 
Hepatic ATF3 (abundance) 0.91 ± 0.14a  0.98 ± 0.18a 2.48 ± 0.81b 
Adipose FAS (abundance) 19.71 ± 2.48a 17.49 ± 1.54ab 13.37 ± 1.90b 
Adipose SREBP-1c (abundance) 5.25 ± 0.85  4.80 ± 0.72 6.97 ± 1.06 
Adipose Akt (% Phospho) 33.10 ± 7.60 38.10 ± 5.0 31.60 ± 4.90 
Adipose p70S6K (% Phospho) 2.32 ± 0.64a 5.38 ± 1.12ab 8.91 ± 1.51b 
Muscle Akt (% Phospho) 42.70 ± 4.11 43.95 ± 4.96 36.77 ±5.86 
Muscle p70S6K (% Phospho) 50.80 ± 4.40 51.75 ± 3.90 50.80 ± 3.80 
 
Values represent means ± SEM; n=6-8. Different letters in a row indicate significant difference, P < 0.05. 
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CHAPTER III: 
DIETARY LEUCINE CONTENT OF ISOCALORIC, ISONITROGENOUS MEALS 
INFLUENCES BODY COMPOSITION, ENERGY PARTITIONING, AND 
MITOCHONDRIAL HOMEOSTASIS 
 
INTRODUCTION 
 Chapter II demonstrated that the carbohydrate / protein ratio has a significant 
impact on post-prandial metabolic responses and that isocaloric exchange of protein at 
the expense of carbohydrate results in favorable metabolic and body composition 
outcomes. This chapter attempts to further describe the metabolic effects attributable to 
the protein component of the diet and examine long-term changes in body composition. 
The primary findings are that the meal-induced stimulation of muscle protein synthesis 
by dietary protein promotes skeletal muscle accretion, reduces dietary energy retention, 
elevates gene expression in muscle mitochondria, and ultimately reduces energy 
storage as body fat. 
Skeletal muscle quality and health are key determinants of the functional 
capacity of an individual, particularly with regards to activities of daily living. Decreases 
in lean body mass are additionally associated with reduced resting energy expenditure 
and a lower functional capacity for physical activity, which contributes to reduced 
voluntary energy expenditure, and subsequently leads to energy storage and fat mass 
increase (20). This pattern compounds in the elderly, as the age-related loss of skeletal 
muscle mass, known as sarcopenia, can contribute to frailty, loss of strength, and it is 
associated with a high incidence of chronic disease (7). It is therefore important to 
identify dietary factors that promote skeletal muscle health and could potentially prevent 
or delay the onset of sarcopenia.  
The continuous process of protein turnover in skeletal muscle involves anabolism 
in the form of muscle protein synthesis (MPS) and catabolism in the form of muscle 
protein breakdown (MPD); the balance of these processes ultimately determines the 
amount of skeletal muscle mass (8). The essential amino acid leucine has a unique 
ability to stimulate MPS, and it appears to act as a signal that an adequate supply of 
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amino acids is available for protein synthesis  (9). Specifically, leucine stimulates the 
mammalian target of rapamycin (mTOR), a component of the insulin signaling pathway, 
which subsequently activates downstream translation initiation factors such as 70-kDa 
ribosomal protein S6 kinase (p70S6K) and eukaryotic initiation factor 4E- binding 
protein1 (4E-BP1)  (2). The leucine content of dietary protein is proposed to be a major 
factor in directing peak MPS stimulation following consumption of a meal (16). 
Our laboratory group has observed an apparent leucine threshold that promotes 
optimal MPS activity, but below which little or no MPS stimulation occurs. This threshold 
is governed by the ability of a meal to elevate plasma leucine concentrations to 
approximately twice the level of a food-deprived state. Specifically, consumption of a 4 g 
complete meal containing wheat protein (47 mg leucine) failed to stimulate MPS in adult 
rats, while consumption of a 4 g complete meal containing whey protein (64 mg leucine) 
sufficiently elevated plasma leucine, activated the mTOR signaling pathway, and 
stimulated MPS. These data indicate that the leucine content of a single meal has an 
acute effect on muscle protein metabolism, but it is not known if this effect compounded 
over time would result in a net accretion of skeletal muscle tissue. There is currently no 
research that supports the potential for chronic leucine supplementation to affect muscle 
mass or body composition long-term (3). Recent studies may be limited by the manner 
in which leucine is administered or consumed. For example, adult rats that were 
provided ad libitum access to chow diet supplemented with 4% leucine for 40 wks had 
no difference in skeletal muscle mass relative to control diet (25). Such approaches that 
gradually contribute additional leucine into the diet are unlikely to significantly elevate 
plasma leucine in comparison to bolus feeding of leucine (or protein), and are therefore 
unlikely to stimulate MPS. On the contrary, a dietary regimen designed to sufficiently 
elevate plasma leucine and optimize the leucine-related stimulation of MPS should 
promote beneficial outcomes with regards to skeletal muscle mass and body 
composition. 
A second interest is the emerging effect of leucine on mitochondria. Cultured 
myocytes treated with leucine demonstrate increased lipid oxidation (22) and 
mitochondrial biogenesis (23), which entails the growth and division of pre-existing 
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mitochondria. Although not explicitly measured, this effect was attributed to increased 
levels of protein synthesis and associated energy demand. A recent study identified that 
addition of branched-chain amino acids (BCAAs) leucine, isoleucine, and valine as 1% 
of the diet significantly increased lifespan in mice, which was associated with an 
increase in skeletal muscle mitochondrial biogenesis (4). The authors suggested the 
mitochondrial effect was due to enhanced nitric oxide signaling, and although they 
made no consideration of protein turnover, they implied that nitric oxide may stimulate 
mTOR and its downstream targets.  
A variety of environmental and energetic stresses can trigger mitochondrial 
biogenesis. These signals are mediated through peroxisome proliferator-activated 
receptor γ co-activator (PGC-1α), which coactivates a series of transcription factors 
(e.g. Tfam, NRF1/2, ERRα) that elevate mitochondrial protein expression and increase 
the capacity for ATP production (24). Aerobic exercise stimulates mitochondrial protein 
synthesis in response to increased demand for energy (19). Protein turnover requires 
substantial ATP consumption; therefore increases in protein turnover could potentially 
provoke a similar response in mitochondria to provide the required energy. This 
experiment was designed to determine if long-term feeding of meals containing protein 
sources that vary in leucine content has differential effects on skeletal muscle mass and 
body composition in relation to the previously observed post-prandial leucine-induced 
stimulation of MPS. In addition, the experiment will evaluate changes in mitochondrial 
status and development in skeletal muscle.  
 
METHODS 
Animals. Male Sprague-Dawley rats (Harlan-Teklad, Indianapolis, IN) with a 
mean body weight of 270 ± 10 g were housed individually in stainless steel wire-
bottomed cages and maintained at 24°C with 12 h reverse light cycle (light: 1900-0700 
h) and free access to water. The animal protocol was approved by the University of 
Illinois Institutional Animal Care and Use Committee. 
Rats were trained to consume three meals / d using a modified AIN-93G diet (17) 
containing 54% of energy from carbohydrate, 16% of energy from protein, and 30% of 
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energy from fat. The meal pattern consisted of a 4 g breakfast meal consumed between 
0700-0720 h, followed by free access to food between 1300-1400 h and 1800-1900 h 
for an adaptation period of 6 d. Rats consumed ~18 g / d of diet during the adaptation 
period. After 3-4 d of adaptation, rats underwent body composition assessment by DXA 
(duel energy x-ray absorptiometry). Following adaptation, rats were randomized to 
consume a treatment diet containing either wheat gluten (WHEAT) or whey isolate 
(WHEY) as the protein source. Wheat gluten was supplemented with lysine in order to 
meet National Research Council guidelines for maintenance and to approximate the 
lysine content of the whey isolate.  
In order to optimize handling of energy and to normalize food intake between 
treatment groups, the treatment diets were fed at 80% of ad libitum intake (14 g / d). 
This was accomplished by feeding three daily meals of discrete amounts: a 4 g morning 
meal consumed between 0700-0720 h, followed by a 4 g afternoon meal 1300-1400 h 
and a 6 g evening meal from 1800-1900 h. Each of the diets was comprised of 
equivalent energy contributions from carbohydrate (54%), protein (16%), and fat (30%). 
As such, these two diets were considered to be isocaloric as well as isonitrogenous. 
The 4 g meals contained approximately 46 mg or 74 mg of leucine from the wheat and 
whey diets, while the 6 g meal contained approximately 69 mg or 111 mg of leucine, 
respectively. The carbohydrate / protein ratio of the diets was 3.375. The composition of 
the treatment diets is shown in Table 3-1. 
Animals consumed the treatment diets for 2 wks, at which point a subgroup of 
animals (n = 8 per group) were deprived from food for 13 h and then either euthanized 
by decapitation (food deprived) or fed their normal 4 g morning meal. Ninety min after 
consumption of the meal rats were euthanized by decapitation and blood and tissues 
were harvested. Tissues were weighed prior to being snap frozen in liquid nitrogen, 
which included gastrocnemius, renal and epididymal fat pads, and liver. Tissues were 
then stored at -80°C until further analysis. The remaining animals (n = 12 per group) 
consumed the treatment diets for 9 additional wks (11 wks total), after which they 
underwent body composition assessment by DXA. After allowing for 3-4 d for recovery 
following DXA, the animals were euthanized in the same manner as at 2 wks. 
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 Determination of protein synthesis. Protein synthesis was measured in skeletal 
muscle using the flooding dose method (10). A 100% enriched L-[2H5]-phenylalanine 
solution (150mmol / L; Cambridge Isotopes, Andover, MA) was administrated at 150 
µmol / 100 g body weight and injected via tail vein (1 mL / 100g body weight). After 10 
min animals were euthanized by decapitation and hind limbs were quickly removed and 
immersed in an ice-water mixture. Gastrocnemius muscles were removed from cooled 
hind limbs, frozen in liquid nitrogen and stored at -80°C. 
 Frozen muscle tissue was powdered in liquid nitrogen, and protein was 
precipitated with cold (4°C) perchloric acid (30 g / L, 1mL per 50 mg muscle tissue). The 
resulting supernatant and protein pellet were prepared for analysis by gas 
chromatography mass spectroscopy as described previously (6). The enrichment of L-
[2H5]-phenylalanine in the muscle hydrolysate was measured by GC-MS using a 6890N 
GC and a 5973N mass detector (Agilent Technologies Santa Clara, CA). Samples were 
run under electron impact ionization and in splitless mode, and phenylethylamine ions at 
mass-to-charge ratio (m / z) 106 (m + 2) and 109 (m + 5) were monitored for 
enrichment.  
The muscle supernatant was used for determination of intracellular free 
phenylalanine enrichment. Free amino acids were purified by ion exchange resin solid 
phase extraction (SPE) using EZ:faastTM amino acid analysis sample testing kit 
(Phenomenex Inc. Torrance, CA, USA) and 2H5-phenylalanine enrichment was 
determined using a propyl chloroformate derivative with GC-MS by monitoring the ions 
at m / z 206 (m) and 211 (m+5) (15).  
Fractional rates of protein synthesis (FSR) were determined from the rate of 
incorporation of L-[2H5]-phenylalanine into total mixed muscle protein as described 
previously (14). The time from injection of the metabolic tracer until tissue cooling was 
recorded as the actual time for L-[2H5]-phenylalanine incorporation. FSR, defined as the 
percentage of tissue protein renewed each day, were calculated according to the 
formula: FSR = (Eb x 100) / (Ea x t) where t is the time interval between injection and 
cooling of sampled tissue expressed in day and Eb and Ea are the enrichments of [2H5]-
Phe in hydrolyzed tissue protein and in muscle free amino acids, respectively. 
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 Plasma measurements. Plasma was obtained from trunk blood by centrifugation 
at 1800 × g for 10 min at 4°C. Plasma insulin concentrations were determined using a 
commercial RIA kit for rat insulin (Linco Research, MO). Plasma leucine concentration 
was determined by HPLC using a Waters 2475 fluorescence detector (18). 
Body composition and energy partitioning. Prior to the administration of the diet 
treatments and 11 wks after the diet treatments began, body fat percentage was 
assessed using dual energy X-ray absorptiometry (DXA) analysis. The DXA instrument 
(Hologic QDR 4500A, software version 11.1:3) was calibrated each day before 
measurement according to the manufacturer’s guidelines. Rats were weighed following 
consumption of their normal morning 4 g meal, and then sedated by intraperitoneal 
injection of dexmedetomidine (0.3 mg / kg) prior to assessment. Rats were then placed 
on the DXA and 3 whole body scans were performed. All scans for a particular rat were 
performed in succession on the same day and analyzed by the same technician. 
Following the scans, rats were revived by intraperitoneal injection of atipamezole 
hydrochloride (1.5 mg / kg), and returned to their housing. 
Total fat mass was obtained by multiplying % body fat as determined via DXA by 
the body weight of the rat on the morning of the assessment. Total lean mass was 
similarly determined by subtracting total fat mass from the body weight. The net fat 
mass gained was obtained by subtracting the total fat mass of the baseline DXA 
assessment (prior to diet assignment) from the total fat mass following 11 wks of 
feeding. The net lean mass gained was obtained similarly. In order to evaluate the 
body- and compartment-specific depositions of energy over the duration of the study, it 
was assumed that lean mass is composed of 20% protein and 80% water, and that fat 
mass is comprised of 80% lipid and 20% water (13). Thus, the net lean mass multiplied 
by a factor of 0.2 approximates the total protein accretion over the course of 11 wks; 
multiplying total protein accretion by 4 kcal / g protein provides an approximation of the 
net energy deposited into the lean compartment. Likewise, the net fat mass multiplied 
by a factor of 0.8 approximates the total lipid accretion over the course of 11 wks; 
multiplying total lipid accretion by 9 kcal / g lipid provides an approximation of the net 
energy deposited into the fat compartment. Finally, total energy deposition was obtained 
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by the sum of net energies deposited into the fat and lean compartments, and the 
percentages of energy deposited to the fat and lean compartments in relation to total 
energy deposited were calculated. 
 Gene expression. Total RNA was isolated from ~50 mg frozen muscle using TRI 
Reagent® (Sigma-Aldrich, St. Louis, MO). First-strand cDNA was synthesized using 
random hexamers on a thermal cycler. RT-PCR was run with 7.5 ng of cDNA template 
and oligonucleotide primers designed to amplify Tfam or cytochrome b in muscle. All 
primers were obtained from IDT (Coralville, IA). The relative abundance of each gene 
was normalized to expression of the 18S control gene.  
Statistical analysis. Data are expressed as mean ± SEM. All variables were 
evaluated for normality and homogeneity of variance by Levene’s test. Group 
differences were assessed by t-test. A one-way ANOVA was performed on MPS with 
the dietary treatment as the independent variable. When a significant effect was 
detected, differences among means were determined using an LSD post hoc test. The 
level of significance was set at P < 0.05. All analyses were performed using SPSS 
Version 15.0 (Chicago, IL). 
 
RESULTS 
Protein synthesis. After 2 wks of consuming the diets containing different protein 
sources, MPS was measured in rats in the fasted condition and 90 min after 
consumption of the standard 4 g morning meal. MPS was not stimulated above fasted 
levels in the WHEAT group, but was significantly elevated (189%) at 90 min after 
consuming the meal in the WHEY group. Similarly, after 11 wks of consuming the diets, 
post-prandial MPS was not different from fasted baseline in the WHEAT group, but MPS 
was significantly elevated (170%) at 90 min after the WHEY meal (Figure 3.1). 
 Plasma measurements. At 2 wks, post-prandial leucine in the WHEAT group was 
not different than the fasted condition; however, post-prandial leucine in the WHEY 
group was significantly elevated above the fasted condition (Table 3.2). This pattern 
was also seen at 11 wks, where post-prandial leucine was elevated following the meal 
in the WHEY group, but not in the WHEAT group. Plasma insulin was elevated above 
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fasted levels following the meal in both the WHEAT and WHEY groups at 2 and 11 wks 
(Table 3.2). 
 Body composition. Animals in the WHEAT group were significantly heavier than 
animals in the WHEY group (Table 3.3). Skeletal muscle (gastrocnemius) was larger in 
the WHEY group, while epididymal fat was heavier in the WHEAT group. There was no 
difference in liver weight between groups. Body fat percentage determined by DXA was 
higher in the WHEAT group (12.7%) than in the WHEY group (9.7%). When these 
percentages were multiplied by total body weight, the animals in the WHEAT group had 
approximately 26% more total fat mass than animals in the WHEY group after only 11 
wks. Total lean mass was not difference between groups.  
In relation to the baseline animals (i.e., wk 0) examined prior beginning the 
treatment diets, animals in the WHEAT group gained more than 3 times the fat during 
11 wks of feeding than animals in the WHEY group (Table 3.3). Similarly, when 
accounting for the energetic equivalent of the accumulated fat and lean tissue, animals 
in the WHEAT group deposited more energy as fat than animals in the WHEY group, 
while the energy deposited as lean tissue was equal between groups. While consuming 
the same calories per day, animals in the WHEAT group deposited more total body 
energy than animals in the WHEY group (Table 3.3). Animals in the WHEY group 
partitioned 59% of deposited energy towards the fat compartment, which was 
significantly greater than the 29% of energy deposited towards fat by the animals of the 
WHEY group. Animals in the WHEY group deposited 71% of energy to the lean 
compartment, which was significantly greater than the 41% of energy that was 
deposited to the lean compartment by the WHEAT animals (Table 3-3). 
 Gene expression. PGC-1α, cytochrome B, and Tfam are a series of genes 
implicated in the progression of mitochondrial biogenesis (24)(24). The relative 
expression of these genes was elevated 49%, 103%, and 36%, respectively in animals 
from the WHEY group. SOD1 is not found in mitochondrial DNA but in somatic DNA, 
although its protein is localized within the mitochondria (12). The relative expression of 
SOD1 was not different between groups (Table 3-4).  
 
49 
 
DISCUSSION 
 This experiment examined if long-term feeding of isonitrogenous protein sources 
with varied leucine contents would produce differential skeletal muscle mass and body 
composition outcomes based on the potential to stimulate (or inability to stimulate) MPS 
following a meal. We found that feeding meals with equal energy and equal total protein 
but different leucine amounts for 11 wks produces differential effects on skeletal muscle 
weight, body composition, efficiency of energy deposition, and energy partitioning, as 
well as on expression of genes related to mitochondrial biogenesis. These findings were 
predicated on the ability of the leucine-rich WHEY protein to elevate post-prandial 
plasma leucine concentrations and to stimulate MPS. After 2 and 11 wks of meal 
feeding, a 4 g meal containing wheat gluten with 47 mg of leucine was unable to 
stimulate MPS, while a 4 g meal containing whey protein with 64 mg of leucine 
stimulated MPS beyond the fasted state. This response indicates that the WHEY group 
experienced more frequent post-prandial stimulations of MPS than WHEAT, which 
resulted in additional accretion of skeletal muscle mass. To our knowledge, these are 
the first data to demonstrate that variations in dietary leucine that produce differences in 
MPS also have a significant effect on skeletal muscle mass.  
 Interestingly, aspects of body composition beyond skeletal muscle mass were 
also impacted by the leucine content of the diet. The WHEY animals were leaner overall 
due to lower total fat mass, which was reflected in tissue weights, as the WHEY animals 
had lighter epididymal fat pads. Since the treatment diets were isocaloric, this suggests 
that the additional fat deposition in the WHEAT animals occurred in the absence of 
skeletal muscle accretion; the energy that was not utilized for MPS must be accounted 
for by other metabolic activity, perhaps in other tissues. However, unexpectedly the 
WHEAT animals were heavier overall, despite equal energy input. This is highlighted by 
the observation that the WHEAT animals deposited ~65% more energy over the course 
of 11 wks.  
Post-prandial thermogenesis, also known as diet-induced thermogenesis (DIT), 
is the energy required for digestion, absorption, and metabolism of nutrients (11). 
Dietary protein has the largest associated DIT in comparison to fat or carbohydrate, 
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which is typically attributed to the energetic costs of catabolism and nitrogen disposal 
via the urea cycle (1). However, the WHEAT and WHEY diets were equal with respect 
to all macronutrients, and yet less energy was deposited by WHEY animals, which 
indicates that there is an additional component of DIT that is not accounted for solely by 
the macronutrient composition of a diet. Furthermore, >50% of the energy deposited by 
the WHEAT group was deposited in the fat compartment, while the WHEY group 
deposited only ~30% of dietary energy into fat tissue. These findings suggest that 
leucine-induced stimulations of MPS produced greater DIT and reduced retention of 
dietary energy, which resulted in differential partitioning of energy among bodily tissues 
producing a more desirable lean phenotype.    
Similar results were recently identified in a knock-out mouse model, where 
deletion of the first step in leucine degradation produced chronically elevated levels of 
plasma leucine (~10 higher than wild type), and resulted in increased energy 
expenditure and obesity lean phenotype (21). The authors attributed the effects to the 
increased energy cost of protein turnover, which was elevated in numerous tissues 
including skeletal muscle, heart, liver, and kidney. Although it was not elevated to such 
a magnitude or duration in the present experiment, the WHEY meals sufficiently 
augmented plasma leucine to stimulate MPS. It is feasible that our results depict a 
similar, more moderate response to physiologically relevant plasma leucine 
concentrations in a wild type model.  
 Despite equal caloric input, we found that the WHEY group deposited less fat 
tissue over 11 wks of feeding. Studies have suggested that dietary leucine can influence 
fat mass in conditions of heavy caloric restriction (5) and diet-induced obesity (26), while 
other research under eucaloric conditions indicates little effect on fat mass (4). In vitro 
treatment with leucine has been shown to increase fatty acid oxidation in C2C12 
myocytes and decrease expression of fatty acid synthetase in 3T3-L1 adipocytes, which 
suggests that leucine may have an effect on energy partitioning, whereby energy 
storage by adipocytes is reduced and fatty acid oxidation in muscle is enhanced (22). It 
is unclear if the differential energy efficiency and partitioning observed in the present 
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study is due to an unidentified direct effect on adipose, or due to a secondary effect 
related to the energy costs of protein turnover in skeletal muscle.  
In support of the latter hypothesis, a group of genes involved in mitochondrial 
biogenesis were induced in skeletal muscle by the WHEY diet. This is perhaps 
indicative of a stress response in which muscle requires more cellular energy to support 
elevated protein synthesis rates. It follows that additional energy substrate could be 
liberated from adipose tissue to be oxidized in muscle for ATP production.  In vitro 
treatment of C2C12 myocytes with leucine stimulated mitochondrial biogenesis and 
increased oxygen consumption (23), which suggests that leucine may either directly or 
indirectly signal muscle to enhance its capacity to produce energy. It is not yet clear if 
stimulation of MPS substantially depletes cellular energy to the extent that increased 
demand for ATP would promote mitochondrial biogenesis.   
 In conclusion, the present study demonstrates that the leucine content of a meal 
impacts post-prandial plasma leucine concentrations such that MPS is stimulated, and 
that these meal effects compounded over a period of 11 wks result in additional 
accretion of skeletal muscle, a lean phenotype, and favorable energy partitioning. 
Furthermore, these meal effects appear to have a positive impact on mitochondrial 
biogenesis in skeletal muscle, which may provide additional support for the additional 
associated energy demand. These findings merit further investigation into the demands 
of leucine-induced MPS stimulation on cellular energy.  
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Figure 3.1. Post-prandial muscle protein synthesis expressed as % of fasted activity in rats fed diets of 
different protein sources for 2 wks. Data are means ± SEM; n = 5-8. * indicates significant difference from 
fasted condition, P < 0.05. 
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 Figure 3.2. Post-prandial muscle protein synthesis expressed as % of fasted activity in rats fed diets of 
different protein sources for 11 wks. Data are means ± SEM; n = 5-8. * indicates significant difference 
from fasted condition, P < 0.05. 
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Table 3.1. Diet composition for treatment groups 
Diet component WHEAT WHEY 
Wheat gluten 190.2 0 
Whey protein isolate 0 188.8 
L-lysine supplement 10.1 0 
Cornstarch 316.7 328.2 
Maltodextrin 134.1 134.1 
Sucrose 101.5 101.5 
Soybean Oil 140.9 140.9 
Cellulose fiber 53.7 53.7 
Mineral mix 37.6 37.6 
Vitamin mix 10.7 10.7 
Choline bitartrate 2.7 2.7 
t-butylhydroquinone 0.014 0.014 
 
Grams per kg diet.  
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Table 3.2. Plasma leucine and insulin at 0 and 90 min after consumption a 4 g meal 
  Timepoint Fasted   WHEAT  WHEY 
Leucine (µmol / L) 2 wks 91 ± 4.4a  78 ± 8.1a  146 ± 28.4b  
  11 wks 84 ± 5.9a 69 ± 3.8a 143 ± 7.8b 
Insulin (pmol / L) 2 wks 140 ± 10.5a 178 ± 9.0b 170 ± 7.2b 
 11 wks 128 ± 15.4a 190 ± 37.7b 171 ± 20.2b 
 
Values represent mean ± SEM; n = 9 for each group at 2 wks, n = 12 for each group at 2 and 11 wks. 
Labeled means without a common letter differ, P < 0.05. 
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Table 3.3. Body composition and energy partitioning measures following 11 wks of meal 
feeding with different protein sources 
  WHEAT WHEY p-value
Body weight (g) 394.2 ± 2.5 384.8 ± 2.4 0.012 
Liver weight (g) 9.08 ± 0.24 9.08 ± 0.23 0.99 
Gastrocnemius weight (g) 2.08 ± 0.04 2.20 ± 0.04 0.006 
Epididymal fat weight (g) 2.82 ± 0.11 2.38 ± 0.14 0.023 
% body fat 12.7 ± 0.5 9.7 ± 0.8 0.011 
Total fat mass (g) 48.5 ± 2.2 38.5 ± 3.3 0.12 
Total lean mass (g) 344.0 ± 3.3 343.3 ± 3.3 0.49 
Net fat gain (g) 17.1 ± 1.7 5.5 ± 3.3 0.007 
Net lean gain (g) 101.3 ± 3.5 101.1 ± 3.3 0.97 
Fat compartment energy gain (kcal) 123.2 ± 12.3 39.7 ± 23.5 0.007 
Lean compartment energy gain (kcal) 81.0 ± 2.8 80.9 ± 2.7 0.97 
Total energy gain (kcal) 204.2 ± 10.6 123.1 ± 23.9 0.004 
% total energy deposited to fat  58.5 ± 3.3 29.3 ± 8.0 0.004 
% total energy deposited to lean  41.2 ± 3.3 70.7 ± 8.0 0.004 
 
Values represent mean ± SEM. n = 12 for each group. 
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Table 3.4. Relative mitochondrial gene expression in skeletal muscle following 11 wks 
of meal feeding with different protein sources 
Gene WHEAT WHEY p-value 
PGC-1α 1.00 ± 0.35 1.49 ± 0.53 0.038 
Tfam 1.00 ± 0.35 2.03 ± 0.71 0.022 
Cyt B 1.00 ± 0.17  1.36 ± 0.33 0.040 
SOD1 1.00 ± 0.35 0.92 ± 0.32 0.72 
 
Values represent mean ± SEM. n = 8-12 for each group. 
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CHAPTER IV: 
THE POST-PRANDIAL MUSCLE PROTEIN SYNTHESIS RESPONSE IS EXTENDED 
WITH SUPPLEMENTAL LEUCINE OR CARBOHYDRATE BY DELAYING CELLULAR 
ENERGY DEPLETION 
 
INTRODUCTION 
 Chapter III revealed that repeated stimulations of muscle protein synthesis (MPS) 
induced by consumption of leucine-rich meals leads to partitioning of dietary energy to 
accretion of skeletal muscle, away from fat storage, and results in more favorable body 
composition. An unexpected finding was that animals consuming the whey-containing 
diet had reduced energetic efficiency despite equal dietary energy input. Additionally, 
consumption of leucine-rich meals was associated with changes in mitochondrial gene 
expression that appear to be in support of the increased energy demand of MPS. 
However, it has not yet been shown that post-meal stimulation of MPS directly impacts 
cellular energy status. This chapter investigates the molecular regulation of MPS to 
determine if the post-prandial anabolic response has a measurable impact on cellular 
energy status.  
Consumption of protein, and particularly consumption of the branched chain 
amino acid leucine, is able to stimulate muscle protein synthesis (MPS) beyond basal or 
fasted levels (6). Leucine stimulates mammalian target of rapamycin (mTOR), a 
signaling kinase and component of the insulin signaling pathway, resulting in activation 
of the downstream translation factors including p70S6 kinase (p70S6K) and eukaryotic 
translation initiation factor 4E-binding protein 1 (4E-BP1). These factors enhance 
translation initiation and subsequent protein synthesis (7). Protein synthetic activity is 
estimated to consume 30-50% of cellular energy across all cell types (4). Due to the 
high energy demands of MPS, a logical assumption is that stimulation of protein 
synthesis beyond basal levels would elevate requisite cellular energy needs.  
To our knowledge, there has been no research that has evaluated the ability of 
dietary leucine to directly affect cellular energy status. However, a study in mice that 
knocked out the first enzyme in leucine catabolism, the branched-chain amino acid 
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transferase (BCAT), resulted in continuously elevated plasma leucine and abnormally 
high protein synthesis rates in numerous tissues, including skeletal muscle, heart, and 
liver (14). These animals had improved glucose tolerance, resistance to diet-induced 
obesity, increased energy expenditure, and a lean phenotype in comparison to the wild-
type. The authors attributed the lean phenotype to a “futile cycle” of energy expenditure 
associated with increased protein synthesis and degradation.  
Separately, a pair of studies in C2C12 myocytes suggests that supplemental 
leucine may have an impact on cellular energy in vitro. The first found that addition of 
leucine to the culture medium stimulated fatty acid oxidation (16), while the second 
found that incubation with a physiologically relevant concentration of leucine increased 
mitochondrial mass and oxygen consumption (17). These effects suggest an adaptive 
response in the capacity to supply cellular ATP, and although it was not directly 
assessed in these experiments, the authors attributed the findings to the elevated 
energy demands of protein synthetic activity.   
The direct effect of leucine on mTOR-stimulated initiation of translation is well 
characterized, and the subsequent increase in translation elongation is responsible for 
~99% of the energy consumption during protein synthesis (4). Recent in vitro research 
suggests that translation elongation is a likely target for regulating the amount of energy 
consumed during protein synthesis. AMP kinase (AMPK) is the key energy sensor of 
the cell; it becomes more active when cellular energy levels are depressed and the 
AMP / ATP ratio is elevated (8). Activation of AMPK by the agonist AICAR inhibited 
translation elongation via increased phosphorylation of eukaryotic translation elongation 
factor 2 (eEF2), resulting in a depression of MPS activity (19). Taken together, these 
reports lead to the hypothesis that leucine-induced depletion of cellular energy by 
activation of MPS would be sensed by AMPK, which would depress translation 
elongation by inhibiting eEF2.  
In evaluation of this hypothesis, it is of interest to determine: 1) if it is possible to 
extend the post-prandial period of MPS with supplemental energy, and 2) does leucine 
directly affect cellular energy status or is the effect indirectly related to triggering the 
initiation process? The following studies evaluated the effect of dietary leucine on 
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cellular energy and translation elongation activity following a meal. In order to determine 
if additional dietary energy can prolong MPS activity, we administered an oral gavage 
solution containing either leucine, carbohydrate, or a combination of leucine and 
carbohydrates to rats 135 min after consumption of a 4 g test meal. In order to 
determine if AMPK responds to MPS-induced reductions in cellular energy by inhibiting 
translation elongation, compounds were injected to inhibit either AMPK activity or MPS 
activity following consumption of a 4 g test meal.   
 
METHODS 
Animals. Sprague-Dawley rats (Harlan-Teklad, Indianapolis, IN) were housed 
individually in stainless steel wire-bottomed cages and maintained at 24°C with 12 h 
reversed light cycle (light: 1900-0700 h) and free access to water. Animal protocols 
were approved by the University of Illinois Institutional Animal Care and Use Committee.  
Rats were trained to consume three meals / d using a modified AIN-93G diet 
(50% of energy from carbohydrate, 20% protein, and 30% fat; Table 4.1) (12). In order 
to normalize food intake and reduce variance in post-prandial metabolism, the treatment 
diets were fed at 80% of ad libitum intake (14 g / d). This was accomplished by feeding 
three daily meals with defined amounts and timing: a 4 g morning meal consumed 
between 0700-0720 h followed by a 4 g afternoon meal 1300-1400 h and a 6 g evening 
meal from 1800-1900 h. 
Experiment 1 evaluated the responses of cellular AMP & ATP, AMPK activity, 
ACC activity (a putative downstream target of AMPK), and eEF2 activity following 
consumption of a leucine-rich meal and following post-meal supplements of leucine, 
carbohydrate, or the combination of leucine plus carbohydrate. After 7 d of meal 
training, rats (n = 34; 270 ± 7 g) were food deprived for 12 h (1900-0700h) then 
euthanized by decapitation, and blood and tissues were harvested (food deprived; n = 
4) or fed the normal 4 g morning meal. Ninety min after consumption of the meal, rats (n 
= 6) were euthanized and blood and tissues were harvested. The remaining rats were 
fed the normal 4 g morning meal and then at 135 min post-meal received an intragastric 
oral gavage of a solution containing either water (sham), carbohydrate (CHO), leucine 
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(LEU), or a combination of carbohydrate and leucine (LC); n = 6 per group. Rats were 
euthanized 45 min later (180 min post-meal) and blood and gastrocnemius muscles 
were harvested. Timing for the gavage was based on previous published research that 
MPS returns to pre-meal rates 180 min following a meal (11). The compositions of the 
gavage supplements were based on previous research that the dose maximally 
stimulates MPS from the fasted state 45 min post-gavage (1). Blood was centrifuged at 
1800 × g for 10 min at 4°C and the serum was decanted. All tissues and blood were 
stored at -80°C until later analyses.    
 The CHO gavage contained 2.63 g of carbohydrate (1.315 g glucose and 1.315 g 
sucrose. The LEU gavage contained 270 mg of leucine, which is equivalent to the daily 
leucine consumption of rats with free access to AIN-93 powdered diet (12). The LC 
gavage contained the same carbohydrate amounts as the CHO gavage, and contained 
the same leucine amount as the LEU gavage. All gavage solutions were prepared in 
distilled water, and all groups received a gavage volume of 5 mL. The sham gavage of 
distilled water was given to reproduce the stress response of the treatment gavages. 
 Experiment 2 utilized specific inhibitors of mTOR and AMPK to evaluate the 
potential for AMPK to inhibit MPS activity via depression of eEF2 activity. After 5 d of 
meal training, rats (n = 10; 250 ± 4 g) were food deprived for 12 h (1900-0700h) and 
then rapamycin (Sigma, St. Louis, MO) (0.75 mg / kg body weight; n = 3) or vehicle (n = 
4) was injected intraperitoneally 120 min prior to consumption of the 4 g test meal. The 
rapamycin treatment was designed to block activation of MPS by specifically inhibiting 
mTOR (2). Compound C (6-[4-(2-Piperidin-1-ylethoxy)phenyl]-3-pyridin-4-
ylpyrazolo[1,5-a]pyrimidine; Sigma, St. Louis, MO) was injected intraperitoneally (30 mg 
/ kg body weight; n = 3) 60 min after introduction of the 4 g test meal. The compound C 
treatment was designed to inhibit AMPK activity (9, 15). Rats were killed 180 min after 
the meal, and tissues were collected and analyzed in a similar manner to Experiment 1.  
Plasma measurements . Plasma was obtained from trunk blood by centrifugation 
at 1800 × g for 10 min at 4°C. Plasma leucine concentration was determined as 
previously described (Chapter III). 
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Determination of muscle protein synthesis. Protein synthesis was measured in 
skeletal muscle as previously described (Chapter III).  
Nucleotide analysis. Adenosine 5'-monophosphate (AMP) and adenosine 5'-
triphosphate (ATP) were determined by HPLC analysis as described in a technical note 
CN-039 by Phenomenex (Torrance, CA). Briefly, frozen gastrocnemius muscle was 
ground under liquid nitrogen and 50 mg of sample was combined with 1 ml of methanol 
in water (25:75) and vortexed. This sample was centrifuged at 10,000 RPM at 4°C for 5 
min and the supernatant extracted. The supernatant was dried and then reconstituted in 
phosphate buffered saline (PBS). The sample was then passed through a Strata X-AW 
33u Polymeric Weak Anion Solid Phase Extraction Sorbent (Phenomenex, Torrance, 
CA). Ten µL aliquots of the final muscle extract were injected onto the HPLC using a 
Phenomenex Gemini 5u C18 110A Column 150 x 4.6 mm with the temperature set at 
25°C. A single mobile phase was utilized at a flow rate of 1 mL / min with 25% 
acetonitrile / 10mM KH2PO4; pH 7.0 (pH was adjusted with potassium hydroxide / 5mM 
tetrabutylammonium chloride). Nucleotide peaks were measured by UV detection at a 
wavelength of 260 nm. Peaks were identified by comparison with external standards 
(Sigma-Aldrich, St. Louis, MO).  
Western blot analysis. Muscle supernatants were subjected to protein 
immunoblot analysis as described previously (Chapters II & III). The activity of eEF2, 
AMPK, ACC, p70S6K, and Akt were determined by measuring the ratio of 
phosphorylated : total antigen. All primary antibodies and anti-rabbit IgG HRP-linked 
secondary antibody were purchased from Cell Signalling (Boston, MA).  
Statistical analysis. Data are expressed as mean ± SEM. All variables were 
evaluated for normality and homogeneity of variance by Levene’s test. A one-way 
ANOVA was performed with the meal time course (fasted, fed, sham, CHO gavage as 
control) or the gavage treatment as the independent variables. When a significant effect 
was detected, differences among means were determined using an LSD post hoc test 
or a Games-Howell post hoc test when variances were not equal. Correlations were 
assessed by Pearson’s linear regression. The level of significance was set at P < 0.05. 
All analyses were performed using SPSS Version 15.0 (Chicago, IL). 
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RESULTS 
Experiment 1 
Plasma leucine. Plasma leucine increased 49% from the fasted condition to 90 
min after the meal and remained elevated 180 min after the meal (Table 4.2). Plasma 
leucine was not different from sham following the CHO gavage, while both leucine-
containing gavages significantly raised plasma leucine (Table 4.3). The Leu treatment 
increased plasma leucine concentration nearly 4-fold above the 180 min sham 
treatment while the LC treatment doubled plasma leucine (Table 4.3).   
Muscle protein synthesis. Relative to the fasted condition, MPS activity was 
doubled at 90 min following consumption of the 4 g morning meal (Figure 4.1). At 180 
min following the meal, MPS in the sham control had returned to the fasted baseline 
level. However, all three gavage treatment groups provided 135 min following the meal 
maintained MPS at the 90 min post-meal level.  
Nucleotides.  There was a trend for the AMP / ATP ratio to be reduced during the 
post-meal period at 90 min compared to the fasted baseline reflecting the increased 
energy available after the meal, but at 180 min after the meal without additional energy 
(i.e., the sham treatment) the ratio was 140% higher than at 90 min. All three gavage 
treatments depressed the ratio to 90 min post-prandial levels (Figure 4.2). 
AMPK and ACC activity. Activity of AMPK was determined by percent 
phosphorylation of the α-subunit at Thr172, where higher phosphorylation indicates 
greater activity. AMPK activity was depressed from the fasted condition at 90 min, but 
returned to fasted baseline activity at 180 min after the meal. All gavage treatments 
depressed AMPK activity at 180 min compared to the sham treatment with values 
similar to 90 min post-meal activity (Figure 4.2). There was a significant inverse 
correlation across conditions between MPS and AMPK activity (r = -0.581).  
Similar to AMPK activity, phosphorylation of acetyl-CoA carboxylase (ACC) was 
depressed at 90 min compared with the fasted baseline, but returned to baseline levels 
180 min after the meal (sham), while all three gavage conditions decreased phospho-
ACC to that of the 90 min post-prandial levels (Figure 4.2). 
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eEF2 activity. As an indicator of translation elongation activity, phosphorylation of 
eEF2 was measured, where greater phosphorylation indicates less elongation activity. 
eEF2 was depressed 44% from the fasted condition at 90 min, but returned to basal 
activity at 180 min after the meal (sham). All gavage treatments depressed eEF2 activity 
from 180 min (sham), similar to 90 min (Figure 4.3). Across all gavage treatments, there 
was a significant inverse correlation between eEF2 activity and MPS activity at 180 
minutes after the meal (r = -0.500; p < 0.05). Additionally, when the fasted group was 
excluded, there was a significant positive correlation between AMPK activity and eEF2 
phosphorylation (r = 0.495; p < 0.05).  
 
Experiment 2 
p70S6K activity. The activity of p70S6K was measured to confirm the ability of 
rapamycin to inhibit mTOR signaling. p70S6K activity was significantly lower in the 
rapamycin group compared to vehicle, while the compound C group was intermediate 
(Figure 4.4). 
AMPK activity. The activity of AMPK was measured to confirm the ability of 
compound C to inhibit AMPK. AMPK activity was not different between compound C 
and vehicle groups, indicating that compound C did not inhibit AMPK. AMPK activity 
was significantly greater in the rapamycin group compared to the compound C and 
vehicle groups (Figure 4.5). 
 
DISCUSSION 
 Increased post-prandial plasma leucine stimulates MPS activity by triggering 
translation initiation via its effects on mTOR signaling. The subsequent increase in 
translation elongation activity results in assembly of the peptide chain and is responsible 
for the majority of energy consumed during MPS activity. These studies were designed 
to determine if cellular energy is depressed following leucine-induced stimulation of 
MPS, and to determine if AMPK responds to such an energy deficit by inhibiting 
translation elongation. 
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 Plasma leucine was elevated at 90 min after consumption of the test meal, and 
remained elevated 180 min after the meal. MPS activity increased 90 min following 
consumption of the test meal, but had returned to basal levels at 180 min. There was a 
trend for AMP / ATP ratio to drop at 90 min after the meal, reflective of an influx of 
energy substrate. However, the AMP / ATP ratio was significantly higher at 180 min, 
indicating a decrease in available cellular energy. These findings are in disagreement 
with an experiment that exposed isolated muscle fibers from chow-fed rats to leucine, 
which stimulated MPS as anticipated (13). However, AMPK activity was reduced 
despite no change in the AMP / ATP ratio. The physiological relevance of this ex vivo 
technique and the accuracy of the nucleotide data is in doubt.  
Both AMPK and ACC activity followed a similar pattern, indicating that AMPK 
responded to the energy depletion associated with an increase in MPS activity. 
Translation elongation activity was assessed by phosphorylation of eEF2, whereby 
increased phosphorylation indicates reduced elongation activity. Alteration in the 
phosphorylation state of eEF2 is the primary mechanism by which elongation activity is 
regulated (5). eEF2 activity at 90 min was reduced from fasted levels, which reflects 
greater translation elongation during peak MPS activity, but was restored at 180 min, 
indicative of basal MPS activity. The 180 min time point was associated with the largest 
energy deficit and the strongest inhibition of translation elongation. These findings are 
consistent with the hypothesis that energy-limited down-regulation of peptide elongation 
is a limiting factor in the duration of post-prandial MPS. 
Previous studies in humans and animals indicate that post-prandial MPS activity 
returns to basal activity at 180 min despite continued elevations in plasma leucine and 
associated initiation factors (3, 11). In order to determine if supplemental nutrients can 
attenuate cellular energy depletion and prolong elevated MPS activity, carbohydrate, 
leucine, or a combination of carbohydrate and leucine were administered orally at the 
point of peak post-prandial MPS activity. Both leucine-containing gavage treatments 
further raised plasma leucine beyond the 180 min time point (sham), although the 
carbohydrate gavage did not. Despite equal leucine contents, the LEU gavage elevated 
plasma leucine to a greater extent than the LC gavage. The cause of different 
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responses to the LEU and LC treatments is unknown. The blunted increase in plasma 
leucine in the LC group may be associated with delayed gastric emptying related to the 
higher osmolality of this gavage with is reflected in lower plasma leucine (18).  
All three treatments were able to extend the peak MPS activity to the 180 min 
time point. Since the carbohydrate gavage failed to further increase plasma leucine, the 
ability to extend MPS is not a leucine-specific effect. Therefore, while leucine acts as a 
unique initiation signal for activating MPS activity, the duration of the post-prandial 
response appears to be influenced by energy substrate. All three gavage conditions 
reduced the AMP / ATP ratio, AMPK activity, and ACC activity relative to sham control. 
This indicates that the supplemental nutrients were sufficient to prevent the MPS-
associated depletion in cellular energy. Across all gavage conditions there was a 
significant negative association between MPS and AMPK activity, suggesting that 
AMPK is responsive to the energy consumption related to MPS activity. Similarly, eEF2 
activity was depressed by each of the three gavage treatments relative to sham control. 
This indicates that the carbohydrate, leucine, and carbohydrate plus leucine gavages 
allowed for continued elevation of translation elongation activity. Consistent with these 
findings there was a significant negative association between eEF2 activity and MPS 
across all treatments. When the fasted group was excluded, an inverse association was 
identified between MPS activity and elongation activity. In total, all three supplemental 
conditions maintained cellular energy at 180 min and reduced eEF2 activity, which 
permitted an extension of peak MPS activity beyond 90 min. 
  It is logical that the magnitude of post-prandial MPS activity is regulated by 
translation elongation since 99% of the energy used to assemble a typical protein is 
consumed during elongation (4). In response to an energy deficit, cessation of 
translation elongation would conserve cellular energy while allowing polysomes to 
remain associated with the mRNA transcript. Thus, when cellular energy is restored to 
adequate levels, elongation could continue without the need to reassemble polysomes. 
As a robust cellular energy sensor, AMPK is an ideal candidate to mediate such a signal 
to the protein synthetic machinery. A proposed mechanism involves AMPK activating 
eEF2 kinase, which subsequently phosphorylates eEF2, thereby inhibiting peptide 
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elongation (10). Interestingly, the leucine gavage was equally capable as the 
carbohydrate-containing gavages of reducing the AMP / ATP ratio and related AMPK 
activity despite providing ~10 times less substrate for energy. No differences in plasma 
insulin could explain this phenomenon (data not shown). The differences in the energy 
content of the supplements suggests that supplemental leucine may exert a unique 
effect on maintaining cellular energy following peak activation of MPS, as plasma 
leucine was elevated 2- to 4-times higher than the sham control.  
 Results from experiment 1 suggest that cellular energy is a key determinant of 
post-prandial MPS activity, and that AMPK senses the MPS-associated energy 
depletion and subsequently inhibits the energetically costly process of translation 
elongation. In order to further elucidate this relationship, an experiment was designed to 
block post-prandial MPS to determine the effect on cellular energy, and separately, to 
block AMPK activity in order to remove its inhibition of translation elongation. We 
hypothesized that inhibition of MPS with rapamycin would prevent the post-prandial 
decrease in cellular energy at 180 min, and that inhibition of AMPK with compound C 
would relieve the inhibition of translation elongation, thus allowing MPS activity to 
continue at peak post-prandial levels. Rapamycin successfully inhibited mTOR 
signaling, as downstream initiation factor p70S6K was less active relative to vehicle. 
However, compound C failed to inhibit AMPK activity, which was no different between 
the compound C treatment and vehicle. As proper inhibition of AMPK was crucial to the 
experiment design, all further analysis of this experiment was abandoned. These results 
highlight a need for further research to identify the molecular mechanisms responsible 
for optimal utilization and protection of cellular energy in response to post-prandial 
activation of MPS.  
In conclusion, the leucine-induced activation of MPS results in a cellular energy 
deficit that is sensed by AMPK. Furthermore, an association between AMPK activity and 
translation elongation activity suggests that AMPK responds to reductions in cellular 
energy by inhibiting the energetically expensive process of translation elongation, 
thereby inhibiting subsequent MPS activity. These findings warrant additional 
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investigation to determine if AMPK has a direct role in limiting post-prandial MPS activity 
when cellular energy is limited.  
71 
 
REFERENCES 
 
1.     Anthony JC, Lang CH, Crozier SJ, Anthony TG, MacLean DA, Kimball SR, 
and Jefferson LS. Contribution of insulin to the translational control of protein synthesis 
in skeletal muscle by leucine. Am J Physiol Endocrinol Metab. 282: E1092-101, 2002.  
2.     Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, and Kimball 
SR. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via 
a rapamycin-sensitive pathway. J Nutr. 130: 2413-2419, 2000.  
3.     Bohe J, Low JF, Wolfe RR, and Rennie MJ. Latency and duration of stimulation 
of human muscle protein synthesis during continuous infusion of amino acids. J Physiol. 
532: 575-579, 2001.  
4.     Browne GJ, Finn SG, and Proud CG. Stimulation of the AMP-activated protein 
kinase leads to activation of eukaryotic elongation factor 2 kinase and to its 
phosphorylation at a novel site, serine 398. J Biol Chem. 279: 12220-12231, 2004.  
5.     Browne GJ, and Proud CG. A novel mTOR-regulated phosphorylation site in 
elongation factor 2 kinase modulates the activity of the kinase and its binding to 
calmodulin. Mol Cell Biol. 24: 2986-2997, 2004.  
6.     Escobar J, Frank JW, Suryawan A, Nguyen HV, Kimball SR, Jefferson LS, 
and Davis TA. Physiological rise in plasma leucine stimulates muscle protein synthesis 
in neonatal pigs by enhancing translation initiation factor activation. Am J Physiol 
Endocrinol Metab. 288: E914-21, 2005.  
7.     Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, 
Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R, and Sonenberg N. 
Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15: 2852-
2864, 2001.  
8.     Hardie DG. AMPK: a key regulator of energy balance in the single cell and the 
whole organism. Int J Obes (Lond) 32 Suppl 4: S7-12, 2008.  
9.     Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran 
TH, and Ronnett GV. C75, a fatty acid synthase inhibitor, reduces food intake via 
hypothalamic AMP-activated protein kinase. J Biol Chem. 279: 19970-19976, 2004.  
10.     McLeod LE, and Proud CG. ATP depletion increases phosphorylation of 
elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR 
signalling. FEBS Lett. 531: 448-452, 2002.  
11.     Norton LE, Layman DK, Bunpo P, Anthony TG, Brana DV, and Garlick PJ. 
The leucine content of a complete meal directs peak activation but not duration of 
skeletal muscle protein synthesis and mammalian target of rapamycin signaling in rats. 
J Nutr. 139: 1103-1109, 2009.  
12.     Reeves PG, Nielsen FH, and Fahey GC,Jr. AIN-93 purified diets for laboratory 
rodents: final report of the American Institute of Nutrition ad hoc writing committee on 
the reformulation of the AIN-76A rodent diet. J Nutr. 123: 1939-1951, 1993.  
13.     Saha AK, Xu XJ, Lawson E, Deoliveira R, Brandon AE, Kraegen EW, and 
Ruderman NB. Downregulation of AMPK accompanies leucine- and glucose-induced 
increases in protein synthesis and insulin resistance in rat skeletal muscle. Diabetes 59: 
2426-2434, 2010.  
72 
 
14.     She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, and Hutson SM. 
Disruption of BCATm in mice leads to increased energy expenditure associated with the 
activation of a futile protein turnover cycle. Cell Metab. 6: 181-194, 2007.  
15.     Shen QW, Gerrard DE, and Du M. Compound C, an inhibitor of AMP-activated 
protein kinase, inhibits glycolysis in mouse longissimus dorsi postmortem. Meat Sci. 78: 
323-330, 2008.  
16.     Sun X, and Zemel MB. Leucine and calcium regulate fat metabolism and energy 
partitioning in murine adipocytes and muscle cells. Lipids 42: 297-305, 2007.  
17.     Sun X, and Zemel MB. Leucine modulation of mitochondrial mass and oxygen 
consumption in skeletal muscle cells and adipocytes. Nutr Metab (Lond) 6: 26, 2009.  
18.     Vist GE, and Maughan RJ. The effect of osmolality and carbohydrate content on 
the rate of gastric emptying of liquids in man. J Physiol. 486 ( Pt 2): 523-531, 1995.  
19.     Williamson DL, Bolster DR, Kimball SR, and Jefferson LS. Time course 
changes in signaling pathways and protein synthesis in C2C12 myotubes following 
AMPK activation by AICAR. Am J Physiol Endocrinol Metab. 291: E80-9, 2006.  
FIGURES AND TABLES 
 
 
Figure 4.1. Muscle protein synthesis after 4g test meal; treatment groups were provided gavage 135 min 
after the meal as water (sham), carbohydrate (CHO), leucine (Leu), or a combination of leucine and 
carbohydrate (LC). Data are means ± SEM; n = 4-6. Means without a common letter differ, P < 0.05 
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 Figure 4.2. Post-prandial ACC activity, AMPK activity, and AMP / ATP ratio after 4g test meal; treatment 
groups were provided gavage 135 min after the meal as water (sham), carbohydrate (CHO), leucine 
(Leu), or a combination of leucine and carbohydrate (LC). Data are means ± SEM; n = 4-6. Means without 
a common letter differ, P < 0.05 
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Figure 4.3. Post-prandial eEF2 activity after 4g test meal; treatment groups were provided gavage 135 
min after the meal as water (sham), carbohydrate (CHO), leucine (Leu), or a combination of leucine and 
carbohydrate (LC). Data are means ± SEM; n = 4-6. Means without a common letter differ, P < 0.05 
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Figure 4.4. p70S6K activity 180 minutes after 4g test meal; treatment groups were injected 
intraperitoneally with 0.9% saline (vehicle) or rapamycin 120 min prior to test meal or with compound C 60 
min after test meal. Data are means ± SEM; n = 3-4; labeled means without a common letter differ, P < 
0.05 
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 Figure 4.5. AMPK activity 180 minutes after 4g test meal; treatment groups were injected intraperitoneally 
with 0.9% saline (vehicle) or rapamycin 120 min prior to test meal or with compound C 60 min after test 
meal. Data are means ± SEM; n = 3-4; labeled means without a common letter differ, P < 0.05 
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Table 4.1. Diet composition 
Diet Component  g / kg 
Whey protein isolate 228.0 
Cornstarch 290.0 
Maltodextrin 134.1 
Sucrose 101.5 
Soybean Oil 140.9 
Cellulose fiber 53.7 
Mineral mix 37.6 
Vitamin mix 10.7 
Choline bitartrate 2.7 
t-butylhydroquinone 0.014 
 
Sources of whey, minerals, and vitamins 
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Table 4.2. Time course changes in plasma leucine in rats fed a complete meal followed 
by leucine-free gavage 
  Fasted Fed Sham 
Time after meal (min) 0 90 180 
Leucine (umol / L) 200 ± 18a 297 ± 31b 312 ± 19b 
 
Values represent Means SEM,n=4-6. Labeled means without a common letter differ, P < 0.05. 
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Table 4.3. Plasma leucine in rats following treatment gavage 
  Sham CHO Leu LC 
Time after meal (min) 180 180 180 180 
Leucine  312 ± 19a 224 ± 40a 1375 ± 122c 671 ± 74b 
 
Values represent Means SEM, n=4-6. Labeled means without a common letter differ, P < 0.05. 
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CHAPTER V: 
SUMMARY AND SPECULATIONS 
 
Protein is known to be essential for maintenance of skeletal muscle and other 
tissues, but recent research suggests that the quantity and quality of dietary protein may 
play an equally important role in the skeletal muscle health of adults. An expanding 
body of literature indicates that moderate substitution of dietary carbohydrate with 
protein leads to improvements in body composition, including maintenance of lean mass 
and reduction of fat mass (7). The benefits of increased dietary protein are frequently 
attributed to greater satiety (8) or to diet-induced thermogenesis (DIT) (12), but these 
mechanisms disregard changes in skeletal muscle and body composition that may be 
associated with the ability of dietary protein and / or carbohydrates to act as signaling 
molecules that regulate metabolism.  
This dissertation sought to investigate the metabolically-active attributes of 
dietary protein and to determine the influence of these responses on body composition. 
In support of previous research, adjustments in the dietary carbohydrate / protein ratio 
altered peripheral insulin signaling and hepatic regulation of glycemia, which affected 
adipose mass and skeletal muscle mass. The impact of dietary protein was isolated by 
demonstrating that the leucine enrichment of a protein source determines its ability to 
promote addition of muscle mass and to increase energy expenditure. Finally, it was 
demonstrated that leucine-induced stimulations of muscle protein synthesis deplete 
cellular energy via translation elongation, and that daily repetitions of this response 
induce mitochondrial biogenesis in response to the increased energy demand. These 
results provide additional insight into the mechanisms by which dietary protein can 
improve body composition and overall health in adults.  
 
DIETARY PROTEIN IMPROVES BODY COMPOSITION 
Clinical trials have shown that moderate substitution of dietary protein for 
carbohydrate can positively influence body composition. These findings were confirmed 
in Chapter II. Healthy, adult rats were fed three complete meals under isocaloric 
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conditions for 25 d with 3 different carbohydrate / protein ratios: 4.8 (HCLP), 1.3 
(MCMP), or 0.6 (LCHP). Animals in the LCHP group had significantly less epididymal fat 
and significantly larger gastrocnemius muscles than the other two groups. These body 
composition outcomes were associated with an increased capacity for adipogenesis in 
both liver and adipose in the HCLP group, which was coupled with insulin insensitivity 
by skeletal muscle. Conversely, the LCHP group had a reduced capacity for 
adipogenesis and improved insulin sensitivity by muscle. These results provide further 
evidence that exchange of protein for dietary carbohydrate can provoke favorable 
responses in peripheral metabolism, which can result in positive body composition 
outcomes within a relatively short period. 
 
DIETARY LEUCINE IMPROVES BODY COMPOSITION  
 A potentially important aspect of dietary protein’s capacity to improve body 
composition lies in its leucine content. The branched-chain amino acid (BCAA) leucine 
has a unique ability among dietary amino acids to stimulate muscle protein synthesis 
(MPS) (4). Our research group has shown that the leucine content of a meal at least in 
part determines the degree to which MPS is stimulated, based on the capacity of the 
meal to elevate post-prandial plasma leucine. The acute response to leucine has been 
well-characterized, but it is not known if repeated stimulations of MPS can have an 
impact on body composition over time by promoting accretion of muscle mass.  
Adult rats were fed three complete meals under isocaloric conditions with diets of 
identical macronutrient components, but with different protein sources (wheat gluten, 
6.8% leucine; or whey protein isolate, 10.9% leucine) for 11 wks (Chapter III). Previous 
results with this model indicated the existence of a “leucine threshold” of approximately 
60 mg per meal beyond which optimal MPS is stimulated, but below which little or no 
MPS stimulation occurs (10). The meals were designed such that the WHEAT group 
would reach the leucine threshold once per day, while the WHEY group would reach the 
leucine threshold three times per day. As anticipated, after 11 wks of feeding the WHEY 
group had larger gastrocnemius muscles. Additionally, the WHEY animals had a 
significantly lower body fat % and larger epididymal fat pads. It is noteworthy that the 
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dietary differences in leucine had an effect on adipose tissue, which suggests that 
chronic responses in muscle provoked a secondary effect in adipose.  
 Further analysis revealed that the WHEY group retained 40% less dietary energy 
over the 11 wks compared to the WHEAT group, and additionally WHEY animals 
preferentially partitioned dietary energy to lean tissue, while WHEAT animals 
preferentially partitioned dietary energy to fat. This was surprising considering the equal 
energetic input among both groups, which leads to the conclusion that the WHEY diet 
induced a greater degree of DIT compared to the WHEAT diet.  
 
DIETARY LEUCINE AFFECTS MITOCHONDRIA  
 In response to the dramatic differences in energy efficiency and partitioning in the 
WHEAT vs. WHEY experiment, it was hypothesized that the increased DIT in the 
WHEY group was due to increased energy consumption by MPS activity. In such a 
scenario, it would be logical that the cell might adapt over time in order to support the 
increased demand for energy. Leucine stimulates synthesis not only of sarcoplasmic 
proteins, but mitochondrial proteins as well (5), and leucine has been shown to 
stimulate the adaptive response of mitochondrial biogenesis in vitro (13) and in vivo (3). 
In Chapter III, selected genes related to mitochondrial biogenesis were analyzed, 
revealing that the WHEY diet induced PGC-1α, Tfam, and cytochrome B in muscle in 
comparison to the WHEAT diet. This apparent induction of mitochondrial biogenesis 
was likely in response to a greater demand for cellular ATP to support the additional 
stimulations of MPS. However, it was not yet known if dietary leucine could acutely 
deplete cellular energy to the extent that would provoke such a response. 
 
POST-PRANDIAL NUTRIENTS IMPACT CELLULAR ENERGY 
Protein synthesis is an energetically costly process, accounting for 30-50% of 
cellular energy expenditure (2). Based on previous results, it was hypothesized that 
leucine-induced MPS activity would substantially deplete cellular energy during peak 
activity. This response was evaluated in adult rats fed a 20% protein test meal that was 
known to optimally stimulate post-prandial MPS (Chapter IV). At 90 min following the 
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meal, the AMP / ATP ratio was slightly depressed, indicating a surfeit of energy 
substrate. However, 90 min later (180 min post-meal), the AMP / ATP ratio was 2.5- fold 
higher, indicating a depletion of cellular energy. This response was reflected by activity 
of AMPK kinase, which is a key energy sensor that is sensitive to the AMP / ATP ratio 
(6). MPS activity was elevated at 90 min post-meal, but after 180 min it had returned to 
baseline. This is in agreement with other studies demonstrating that leucine-induced 
elevations last < 3 hrs (1, 10). 
Translation elongation has been reported to be a likely candidate for energy-
sensitive regulation of protein synthesis, since it consumes 99% of the energy required 
by the process (2). The activity of translation elongation factor eEF2 was depressed at 
180 min post-meal, corresponding with a high AMP / ATP ratio and AMPK activity. 
Evidence suggests that AMPK can inhibit translation elongation via AMPK (11). This 
data suggests that leucine-induced activation of MPS results in a temporary cellular 
energy deficit that is sensed by AMPK kinase, which then inhibits subsequent 
translation elongation in order to prevent over-depletion of cellular energy. This 
hypothesis was supported by the ability of post-meal supplemental nutrients in the form 
of carbohydrate or leucine to overcome the MPS-associated reduction of cellular 
energy, thusly providing more energy for translation elongation to continue.  
 
LIMITATIONS AND FUTURE DIRECTIONS 
The data presented in this dissertation are not without limitations. In Chapter III, it 
appears likely that DIT was truly different between the WHEAT and WHEY groups. 
However, resting energy expenditure and physical activity were not appropriately 
assessed to ensure that the different patterns of energy partitioning were truly a result of 
enhanced DIT in WHEY. Future experiments assessing the potential for dietary leucine 
to uniquely affect thermogenesis should consider these measurements. Additionally, the 
WHEAT vs. WHEY experiment was designed to assess the ability of dietary leucine to 
influence muscle tissue mass, and so it was unexpected to subsequently determine that 
mitochondrial function was influenced by the leucine content of the diet. Present results 
provide evidence that a series of genes related to mitochondrial biogenesis were 
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induced in muscle by WHEY, and indeed these are compulsory for the process (9), but 
in order to definitely identify that mitochondrial biogenesis has occurred, numerous data 
regarding initiation stimuli, gene transcription and expression, and physical 
measurements of the mitochondrial structure should be shown. An attempt to 
characterize induction of certain mitochondrial proteins was undertaken, but the tissues 
had been stored for ~2 years before these were determined to be useful measurements, 
and unfortunately the reduced integrity of the tissues yielded no results. Therefore, a 
need exists for future experiments to consider numerous measurements, including 
tissue microscopy, to confirm that dietary leucine truly affects the status of mitochondria.  
 
CONCLUSION 
 In summary, this dissertation has shown that dietary protein and leucine 
favorably impact body composition. Repeated consumption of leucine-rich meals 
stimulates MPS and promotes accretion of new skeletal muscle. These leucine-induced 
activations of MPS result in a temporary deficit of cellular energy, which may regulate 
the duration of related translation elongation activity to spare energy for essential 
cellular processes. The repeated depletions of cellular energy following chronic 
consumption of leucine-rich whole meals appear to be sensed by an unknown 
mechanism, which initiates mitochondrial biogenesis to increase the capacity for ATP 
production in order to meet the additional energy demand of translation elongation. This 
expansive use of cellular energy may result in substantially greater energy consumption 
at the organism level, therefore comprising an as-of-yet unidentified component of 
dietary thermogenesis related to protein consumption, which is depicted in Figure 5.1. 
These findings and speculations provide additional insight into the means by which 
dietary protein positively influences body composition. 
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FIGURES 
 
 
 
Figure 5.1. A proposed model accounting for the high relative diet-induced thermogenesis of protein; 
consumption of protein-containing meals that are appropriately enriched in leucine stimulates MPS, which 
temporarily depletes cellular energy and activates AMPK. When the process is repeated over time, the 
transcriptional activity of PGC-1α is elevated, which stimulates mitochondrial biogenesis. The capacity for 
fatty acid oxidation is thereby increased to provide the ATP required to support MPS activity. In addition 
to accretion of lean muscle mass, the MPS-associated energy demand affects whole body energy 
partitioning and improves body composition. Consumption of meals that are not adequately enriched in 
leucine fails to elevate MPS activity, such that cellular energy is not impacted. Therefore, the AMPK- 
PGC-1α-mitochondrial axis is not induced, and the positive effects on energetics and body composition 
are not realized. 
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